Dermatology Video Statistics

Key takeaways

1. Dermatologists and dermatology practices posting as themselves made 42.6% of the on-topic videos among YouTube’s most-viewed dermatologist, skin cancer check and acne treatment results but drew 38.7% of their views; estheticians, spas and beauty creators drew 40.4% (our read, Nov 7, 2026). (Mark Studios) See details
2. Acne titles drew 55.5% of those views and pimple-popping and extraction videos 36.3%; videos of 60 seconds or less drew 62.4%. (Mark Studios) See details
3. Across six peer-reviewed studies of top dermatology videos (searched 2018 to 2024), the median share made by or involving dermatologists was 22.3%, and across the four TikTok-only studies 15.2% (our calculation). (Mark Studios) See details
4. 12,616 dermatologists billed Medicare Part B fee-for-service in 2024, Medicare’s payments to dermatologists rose 14.4% from 2019 before inflation, and 146 of them had a Palm Beach County address. (CMS) See details
5. BLS put the median annual wage of U.S. wage-and-salary dermatologists at $328,730 in May 2025, 6.4 times the median for all occupations; it published no 2025 dermatologist estimate for Florida or its metro areas. (BLS) See details
6. The American Cancer Society projects 112,000 new invasive melanoma cases in the U.S. in 2026, 9.4% of them in Florida (our calculation); SEER puts the lifetime risk of a melanoma diagnosis at about 2.2 percent. (NCI SEER) See details
7. The “1 in 5 Americans will develop skin cancer by age 70” line rests on Stern’s 2010 model of how many 70-year-olds have already had a basal or squamous cell cancer, not a lifetime forecast; and “SPF 30 blocks 97%” assumes a lab-thick layer, while Danish beachgoers in a 2018 study applied enough for an effective SPF of 2.3. (Archives of Dermatology) See details

Who makes the most-viewed dermatology videos on YouTube?

Dermatologists make the most of them, but spas and beauty creators draw more of the views. In our November 2026 read of YouTube, dermatologists and dermatology practices posting as themselves made 42.6% of the on-topic videos among the most-viewed dermatologist, skin cancer check and acne treatment videos and drew 38.7% of their lifetime views, while estheticians, spas and skincare or beauty creators made 22.6% of the videos and drew 40.4% of the views (our count). We read YouTube’s own view-sorted search results for 'dermatologist', 'skin cancer check' and 'acne treatment' on November 7, 2026, the first four pages for each, through the YouTube Data API with no country filter, and classified every channel by hand from its own title, description and video text.

The three lists held 586 unique videos from 277 channels, with 4,140,123,325 lifetime views in all. They barely overlapped: 11 videos were in two lists and none was in all three. Leaving out one off-topic video, a veterinarian’s video on cancer in dogs, leaves 585 on-topic videos with 4,139,991,201 views, and the median one had 2,860,176 views. View counts are lifetime snapshots and include ad views.

64 dermatologist or dermatology practice channels appeared, and 52 of them called themselves dermatologists or board-certified dermatologists in their own text; the rest gave only a dermatology practice name or 'skin specialist' wording, and a few were dermatology physician assistants. We did not check any licence or board certification. The median video from a dermatology channel had 3,356,343 views.

How much of dermatology YouTube comes from a few channels?

About half of it. The ten biggest channels drew 52.8% of the on-topic views in our November 7, 2026 sample, and the three biggest, SAC DEP SPA, Dr. Aanchal MD and 208SkinDoc, drew 27.4% (our count). The ten most-viewed videos alone drew 20.4% of all on-topic views.

SAC DEP SPA, a Vietnamese acne-treatment spa that posts long extraction videos, drew 16.2% of the on-topic views on its own and posted 38 of the videos, more than any other channel. Dr. Aanchal MD, an Indian dermatologist trained at AIIMS New Delhi, posted the most videos of any dermatologist and drew 6.2% of the views.

The single most-viewed video was not from a doctor at all: a 16-second Safeguard Philippines ad for a 'Derm-Protect' face and body wash billed as 'Dermatologist-Tested', with 178,243,853 views. Second came Chung Vo Spa’s 61-second 'Hidden Acne 036', with 123,522,419 views. The most-viewed video from a dermatologist’s own channel was Dr. Timothy Jochen’s 31-second 'We Treated Her Acne in just One Day!', with 84,939,019 views, and 208SkinDoc’s 20-second 'Derm reacts to MASSIVE pimple!' had 78,796,693.

Who else posts skin and acne videos?

Mostly spas and creators, then other doctors and health systems. Acne-extraction spa channels, nearly all of them Vietnamese, drew 27.6% of the on-topic views in our November 7, 2026 sample, and skincare and beauty creators without a clinical credential drew 10.8% (our count). Brands and sellers, mostly skincare and pimple-patch brands, drew 10.3%.

Other doctors and clinicians, such as plastic surgeons, aesthetic doctors, GPs and oncologists, made 9.6% of the on-topic videos but drew only 4.3% of the views. Hospitals, cancer centres, health systems, associations and medical-education channels made 9.6% of the videos too, but drew 0.8% of the views; the American Academy of Dermatology’s own channel had 172,746 views across its videos in the sample. Media, TV, news and podcast channels drew 1.1%. Patients and individuals telling their own acne or skin cancer story drew 2.3%, and faceless, animation and re-post channels drew 0.7%. We do not name the people behind patient-story channels.

Where are the dermatology channels based, and do Florida practices appear?

Mostly outside the United States. Dermatologists and dermatology practices outside the United States, mostly in India, drew 24.6% of the on-topic views in our November 7, 2026 sample, against 14.2% for U.S.-placed dermatologists, who posted 14.0% of the videos (our count). Dermatology channels with India as their country setting drew 16.7% of all on-topic views. Channels of any kind whose country setting was the United States posted 31.1% of the on-topic videos and drew 29.2% of the views.

Florida barely appears. 3 channels placed themselves in Florida in their own text, Mayo Clinic, O’Donoghue Dermatology in Sarasota and Jupiter Dermatology & Hair Restoration, and their on-topic videos had 1,196,071 views in all. 2 of the dermatology channels were Florida practices: O’Donoghue Dermatology and Jupiter Dermatology & Hair Restoration. Jupiter Dermatology was the only channel in Palm Beach, Broward or Martin County, and its one video in the sample, a DermTech melanoma sticker test, had 110,073 views.

What does each search return?

Each search returns a different mix of channels. Dermatologists’ own channels drew 81.6% of the views of the on-topic videos in YouTube’s most-viewed results for 'dermatologist' on November 7, 2026, and 83.8% of those videos ran 60 seconds or less (our count). For 'acne treatment', estheticians, spas and beauty creators drew 66.7% of the views and dermatologists 14.1%, and the median video had 6,592,311 views.

'Skin cancer check' returns a far smaller audience. The median on-topic video in that list had 229,847 views. Dermatologists’ own channels drew 37.2% of its views, and hospitals, cancer centres, health systems, associations and medical-education channels made 27.1% of its videos. 46 of its on-topic videos were about other cancers, such as breast, oral or blood cancer, not skin cancer.

What are the most-viewed dermatology videos about?

Acne, and above all pimple popping. Titles about acne, pimples, blackheads or whiteheads made 33.3% of the on-topic videos on November 7, 2026 but drew 55.5% of the views (our count, a regex on titles with every match read by hand). Pimple-popping, extraction and drainage videos made 16.1% of the videos and drew 36.3% of the views, with a median of 8,829,083 views; 79 of them came from spas, estheticians and beauty creators rather than dermatologists.

Skin cancer is the reverse: many videos, few views. Titles about skin cancer, melanoma, moles or skin checks made 25.5% of the on-topic videos but drew 3.3% of the views, with a median of 198,429. Dermatologists’ own channels drew 59.5% of the views of those skin cancer and mole videos.

Product talk is the dermatologists’ home ground. Videos titled about skincare routines and products, from face washes and serums to sunscreens and shampoos, drew 29.1% of the views, and 99 of those titles came from dermatologists’ own channels. 39 videos were 'dermatologist rates' or 'rating ... as a dermatologist' videos, all from dermatologists. 'Derm reacts' and 'dermatologist reacts' videos drew 6.5% of the views, and 30.6% of all on-topic titles used the word 'dermatologist' or 'derm', hashtags included.

Some subjects barely show. 19 titles were about sunscreen, SPF, UV or sunburn, most of them from dermatologists. Only 3 named eczema or dermatitis, and psoriasis appeared in a single title. Titles about lasers, chemical peels or fillers drew 3.6% of the views.

How long and how new are the most-viewed dermatology videos?

Mostly short and recent. Videos of 60 seconds or less were 60.7% of the on-topic videos on November 7, 2026 and drew 62.4% of the views (our count). The median short had 3,563,543 views, against 1,880,747.5 for longer videos. 59.5% of on-topic videos were published in 2024 or later, and 85 in the year before our read.

YouTube’s altered or synthetic content field was absent from all 586 videos, and the made-for-kids flag was off on every one (our read of videos.list part=status). That includes Fauquier ENT’s 'Melanoma Skin Cancer Development Time Lapse', which its own description says was made 'Using generative AI'; it had 1,650,513 views.

How often do U.S. dermatologists post to YouTube?

Often: the median U.S. dermatology channel in our sample posted 136 videos in the year to November 7, 2026. We read the full year of uploads of every U.S.-placed dermatologist or dermatology practice channel in the search sample, and together they posted 6,629 videos (our count, channels.list, the uploads playlists and videos.list). 16 of them posted 100 or more videos in the year, and a few posted less than one a month. DermAngelo, a board-certified dermatologist’s channel of 'dermreacts' shorts, posted the most, 1,188; we read views for only its newest uploads, so it is left out of the view figures below.

The uploads of the other channels, which we read in full, had a median of 30,328 views, and 52.4% ran 60 seconds or less. Dr. Pimple Popper’s uploads in the year had a median of 310,382.5 views. Practice and group channels, such as Tareen Dermatology, Las Vegas Dermatology and U.S. Dermatology Partners, did much worse: their uploads had a median of 776 views. The Florida practices posted little: Jupiter Dermatology & Hair Restoration in Palm Beach County posted 46 videos in the year and O’Donoghue Dermatology in Sarasota 5.

Who makes the dermatology videos people find on YouTube and TikTok?

Mostly people who are not dermatologists: across six peer-reviewed studies of top dermatology videos, published or searched between 2018 and 2024, the median share made by or involving dermatologists was 22.3% (our calculation), and across the four TikTok-only studies it was 15.2% (our calculation). Each study sampled the top results for one topic on one date, and each defined “dermatologist” its own way, so the table below gives every study’s year, platform, sample and finding side by side. Quality scores use DISCERN (1 to 5, higher is better) or the Global Quality Scale (GQS, 1 to 5).

The audience is large. The dermatology hashtags in the 2021 TikTok study showed 18.68 billion views between them on TikTok’s own counters, most on skin-condition tags (JMIR Dermatology). Among 162 TikTok dermatology influencers identified from top posts on February 26, 2021, 14 were dermatologists (8.6%) (JMIR Dermatology), and 57.1% of those 14 showed promotional content such as ads, discounts or brand tags (JMIR Dermatology). A 2026 study found 65 board-certified dermatologists with 100,000 or more followers on Instagram or TikTok; those who posted more often and on more platforms had larger followings (Cutis). For cosmetic procedures on social media, see our aesthetics video statistics.

Do dermatologists’ videos get more views, and are they more reliable?

Their videos score higher on quality but are not reliably more popular: in the June 2023 #acne study, the 38 physician-made TikToks averaged 712,370 views against 312,317 for non-physician videos (Cureus), 2.3 times as many (our calculation), and dermatologists’ videos drew about the same engagement as other physicians’. In a 2024 study of TikTok psoriasis-treatment videos, physicians scored a mean DISCERN of 1.76 against 1.44 for non-physicians, with no significant difference in engagement (Journal of Drugs in Dermatology). In the September 2024 melanoma sample, 72% of the 18 physician creators were dermatologists (JMIR Dermatology), and physicians’ videos outscored nonphysicians’ on both quality and likes. In the 2025 vitiligo study, non-providers made most of the videos and drew more engagement. In the August 2024 sunscreen study, accuracy fell as likes and views rose (JMIR Dermatology).

Scores are low across the board. The median of the mean DISCERN scores in four English-language studies above (YouTube psoriasis; TikTok acne, melanoma and topical steroid withdrawal) was 1.95 out of 5 (our calculation). Studies of German-language YouTube videos and of Chinese platforms are not in this summary.

How much sunscreen misinformation is on TikTok?

Little of the most-viewed content, but it draws outsized reactions: in a 2026 analysis of 971 of the most viewed TikToks under five sunscreen hashtags, 86.8% promoted sunscreen use (PLOS Digital Health) and 1.5% claimed sunscreen causes harm; videos that only criticised sunscreen drew significantly more likes, shares and comments than videos that only promoted it (PLOS Digital Health). The 321 English-language TikToks tagged #nosunscreen collected in July 2024 averaged 73,121 views each (Cancer Control). Children’s skin care videos also leave sunscreen out: in a 2025 study of 100 TikTok regimen videos by creators aged 7 to 18, only 26.2% included sunscreen (Pediatrics).

Does video education help dermatology patients?

It usually raises knowledge: in a 2011 U.S. randomized trial of 94 participants, an online sunscreen video beat a pamphlet on knowledge and on reported sunscreen use at 12 weeks (Patient Education and Counseling). Effects on behaviour and anxiety are mixed. The trials below are small, mostly single-center, and several measured outcomes by questionnaire.

How accurate is teledermatology, and does it shorten waits?

A 2023 meta-analysis of 44 studies (2010 to May 2022) found 68.9% pooled agreement between teledermatology and face-to-face diagnoses (BMJ Open), rising to 71% when dermatologists did both consults, against 44% for non-specialists (BMJ Open). For skin cancer, a 2018 Cochrane review found photo-based teledermatology picked out malignant lesions with a summary sensitivity of 94.9% in four studies (Cochrane), and a 2017 review of 21 studies put teledermatology’s agreement with the reference standard at 51%-85%, against 67%-85% in person (JAMA Dermatology). Most of these studies were small and at risk of bias.

In an urban U.S. safety-net system that ran 3,285 store-and-forward consults from 2014 to 2017, patients sent on for an in-person visit waited a median 36 days (Telemedicine and e-Health), against 64 days through standard referral (Telemedicine and e-Health), 43.8% shorter (our calculation). Use jumped during COVID-19: a 2022 study of Medicare Part B billing data found a 210-fold increase in teledermatology evaluation and management visits from 2019 to 2020 (Clinics in Dermatology). In a survey of 338 practicing U.S. dermatologists published in 2023, those who adopted teledermatology before the pandemic used it for 19.6% of visits against 10.4% for later adopters, yet were more likely to expect to use it less (Journal of Drugs in Dermatology).

How long do patients wait to see a dermatologist?

In a 2021 secret-shopper study of 611 clinics in 28 states, a caller with a new, changing mole waited a median 7 days with Blue Cross Blue Shield or Medicare (JAMA Dermatology) and 13 days with Medicaid (JAMA Dermatology), 1.9 times as long (our calculation); Medicaid callers got an appointment in only 17% of calls (JAMA Dermatology). Academic clinics were far slower in a 2026 secret-shopper study of 113 residency-affiliated clinics, where the median wait for an urgent changing or bleeding mole was 71.5 days (Clinics in Dermatology). In 15 large metro areas in 2017, new private-sector dermatology patients waited a mean 32.6 days against 15.6 at VA medical centers (JAMA Network Open). The oldest baseline, a 2006 scripted-call study of 851 dermatologists, found Medicare patients with a changing mole waited a mean 38.9 days (Journal of the American Academy of Dermatology). These studies use different callers, complaints and averages (median or mean), so they show ranges, not a trend.

U.S. dermatologist density rose from 3.02 to 3.65 per 100,000 people between 1995 and 2013, while the gap between urban and rural areas widened as dermatologists settled in well-resourced cities (JAMA Dermatology). Across 557 health service areas in 2017-2021, areas with more than 4 dermatologists per 100,000 people had 20% lower odds of a late-stage melanoma diagnosis than areas with none; the study shows an association, not cause (Journal of the American Academy of Dermatology).

How many dermatologists are there in the U.S.?

The Association of American Medical Colleges (AAMC) counted 12,756 active dermatologists in the United States on December 31, 2021, from the AMA Physician Masterfile (AAMC). Women were 52.2% of them (AAMC), and 44.8% were aged 55 or older (AAMC). The AAMC’s newer counts sit in an interactive dashboard that cannot be linked table by table, so this page cites its archived 2022 report. The government employment and wage counts for dermatologists are in the workforce section; they are counted a different way.

How many dermatologists practice in Florida, and in Palm Beach, Broward and Martin counties?

Florida’s Department of Health counted 1,249 dermatologists providing direct patient care in its 2023–25 physician workforce survey, which physicians answer when they renew a license (Florida DOH). The survey’s base is the 62,209 responding physicians of all specialties who provide direct patient care (Florida DOH).

Palm Beach County had 158 of those dermatologists (Florida DOH), Broward County 99 (Florida DOH) and Martin County 8 (Florida DOH). Together the three counties had 265, or 21.2% of the state’s total (our calculation).

123 Florida dermatologists in the same survey said they plan to stop providing direct patient care in Florida or change specialty within five years (Florida DOH). That is about 9.8% of the dermatologists counted (our calculation; the two numbers come from different tables of the same survey).

How much of dermatology is owned by private equity?

By 2022, corporate chains, nearly all backed by private equity, employed 16% of U.S. dermatologists who bill Medicare, according to Staiger and colleagues in Health Affairs Scholar (2026), who sorted dermatologists by practice owner using Medicare claims and deal records for 2012–2022 (Health Affairs Scholar). Independent practice fell from 62% of dermatologists in 2012 (Health Affairs Scholar) to 44% in 2022 (Health Affairs Scholar). Hospitals or health systems owned the practices of 26%, the largest owner group after independent practice (Health Affairs Scholar).

An earlier count of deals, by Tan and colleagues in JAMA Dermatology (2019), found that private equity-backed dermatology management groups acquired 184 practices between May 2012 and May 2018 (JAMA Dermatology). Acquisitions rose from 5 in 2012 (JAMA Dermatology) to 59 in 2017 (JAMA Dermatology). 36% of the clinics tied to those practices were in Texas and Florida (JAMA Dermatology). The study counted purchases of existing practices only, not new clinics the groups opened.

Braun and colleagues, using commercial insurance claims for 2012–2017, found that one in eleven dermatologists practiced in a private equity-owned practice by 2017 (Health Affairs). One and a half years after a purchase, prices paid to those dermatologists for routine medical visits were 3-5 percent higher than prices paid to other dermatologists; the study found no consistent change in total dermatology spending (Health Affairs).

What do dermatology associations count, and what did their surveys find?

The American Academy of Dermatology (AAD), the dermatologists’ professional association, says it has more than 21,000 member physicians worldwide (AAD).

In a survey the AAD commissioned from Versta Research, 1,140 U.S. adults answered online from January 20 to February 5, 2025 (AAD). 96% said sun protection is important (AAD), and 1 in 4 cited the influence of a dermatologist as the reason (AAD). 35% said they were sunburned in 2024 (AAD), up from 25% in the AAD’s 2020 survey, whose sample the release does not give (AAD). These are the association’s own survey results; its members treat sun damage.

The American Society for Dermatologic Surgery (ASDS), whose members sell cosmetic treatments, surveyed more than 3,500 U.S. consumers for its 2025 cosmetic procedures survey; the release gives no field dates (ASDS). 74% follow the social media of the provider they see or are considering, and nearly half say a provider’s social media presence affects whether they book (ASDS). The aesthetics video statistics page covers the rest of that survey.

Can a dermatologist’s channel get YouTube’s health source label?

Yes, if the channel clears YouTube’s bar: as read in November 2026, a licensed professional’s channel needs more than 1,500 valid public watch hours in the last 12 months to qualify for YouTube’s health source information panels and health content shelves (YouTube). The eligible professions start with “Licensed Doctor (eligible to practice medicine in the relevant country)”, which covers dermatologists (YouTube). YouTube says it typically decides on an application in about 1-2 months (YouTube). It excludes “certain types of for profit healthcare brands” and channels run by drug, insurance or medical device companies (YouTube). Individual U.S. professionals have been able to apply since October 27th, 2022 (YouTube).

What do Google’s ad rules say about dermatology ads?

Google Ads lists Health among the sensitive interest categories whose ads face targeting restrictions, as read in November 2026 (Google). Its healthcare policy does not allow prescription drug terms in ad text, landing pages or keywords, except for sites only for healthcare professionals, brick-and-mortar pharmacies and drug makers (Google). In the United States, telemedicine providers, including teledermatology services that prescribe, can advertise only if accredited by LegitScript (Google).

How many dermatology residency positions were offered in the 2026 Match?

Dermatology programs offered 546 advanced (PGY-2) positions in the 2026 Main Residency Match, according to the National Resident Matching Program (NRMP), which runs the Match (NRMP). That is up from 492 in 2022 (NRMP), a rise of 11.0% (our calculation). Counting first-year and reserved physician positions as well, the NRMP counted 602 dermatology positions in 2026 (NRMP).

1,103 applicants ranked at least one PGY-2 dermatology program in 2026 (NRMP), against 851 in 2022 (NRMP), a rise of 29.6% (our calculation). That is 1.73 ranking applicants per position in 2022 and 2.02 in 2026 (our calculation). U.S. MD seniors filled 79.5% of the 2026 PGY-2 positions (NRMP).

How hard is it to match into dermatology?

U.S. MD seniors who preferred dermatology matched to it 62.6% of the time in 2026, the lowest rate among the specialties in the NRMP’s Charting Outcomes report (NRMP). 272 of those seniors did not match to dermatology (NRMP). Across all applicants, 1,099 people preferred dermatology (NRMP), or 1.83 for each position offered (NRMP). The NRMP’s “applicants who ranked” and “applicants who preferred” are different counts, so the per-position figures in this section and the one above differ.

How many dermatology residents are in training?

The Accreditation Council for Graduate Medical Education (ACGME) accredited 145 dermatology residency programs in academic year 2024–2025 (ACGME), with 1,704 active residents (ACGME). Women were 65.3% of dermatology residents (ACGME), and 87.0% had graduated from U.S. MD-granting (LCME-accredited) medical schools (ACGME). There were 84 accredited Mohs surgery fellowships (micrographic surgery and dermatologic oncology) (ACGME), training 97 fellows (ACGME).

How many physicians pass the dermatology board’s exams?

574 physicians passed the American Board of Dermatology’s (ABD) APPLIED Exam in 2025 (ABD), a pass rate of 99.1% (ABD). The ABD certified 92 physicians in Micrographic Dermatologic Surgery, its Mohs surgery subspecialty, on September 23, 2026 (ABD). The board describes the route as four years of college, four years of medical school, a year of internship and three years in specialized dermatology training before the certifying exams (ABD).

How many dermatologists bill Medicare?

CMS's Medicare Physician & Other Practitioners file lists 12,616 dermatologists who billed Medicare Part B fee-for-service in 2024 (CMS). That is 1.0% of the 1.3 million provider records (1,296,739) of all specialties in the same file (CMS; our calculation). The file counts only original Medicare claims: dermatologists who saw only Medicare Advantage patients, or no Medicare patients, are not in it.

CMS now lists some Mohs surgeons apart from other dermatologists. The 2024 file has a separate provider type, 'Micrographic Dermatologic Surgery', with 383 providers (CMS), 29 of them in Florida (CMS). No 2024 provider type has 'Mohs' in its name, and the 2019 file has no dermatology type other than 'Dermatology'. Counting both 2024 types, 12,999 providers billed Medicare (our calculation). The figures below are for the 'Dermatology' type unless they say otherwise.

The count grew slowly. CMS's 2019 file lists 12,102 dermatologists (CMS), so the number rose 4.2% in five years (our calculation). In Florida it rose 5.3%, from 992 in 2019 (CMS) to 1,045 in 2024 (CMS). Florida holds 8.3% of the U.S. total, second only to California (our calculation).

Most practise in cities: 93.2% of dermatologists billing Medicare in 2024 have an address CMS codes as a metropolitan core (RUCA 1) (our calculation from the CMS file).

How much does Medicare pay dermatologists?

Medicare paid dermatologists $3.27 billion (3,266,719,398) for Part B fee-for-service services in 2024, summing CMS's by Provider file (our calculation). In 2019 it paid $2.86 billion (2,856,429,955), so payments rose 14.4% in five years before inflation (our calculation). Dermatologists billed 52.8 million services (52,844,459) in 2024 (our calculation). Providers listed under the separate 'Micrographic Dermatologic Surgery' type were paid another $280.5 million (280,496,131) (our calculation).

The typical dermatologist's Medicare income fell. The median dermatologist received $134,811 from Medicare Part B in 2024, down from $140,771 in 2019, before inflation (our calculation). The median Florida dermatologist received $223,901 in 2024 (our calculation). Medicare paid Florida dermatologists $449.6 million (449,565,502) in 2024, up from $380.2 million (380,195,662) in 2019 (our calculation).

Payments are concentrated. 453 dermatologists received $1 million or more from Medicare Part B in 2024, up from 347 in 2019; together the 2024 group received 27.0% of Medicare Part B payments to dermatologists (our calculation). The top 10% of dermatologists by payment received 45.5% (our calculation).

Products and radiation make up part of the total. Drugs and biologicals, the lines CMS flags as drugs, were 9.8% of the Medicare payments on dermatologists' non-suppressed service lines in 2024 (our calculation). Skin substitute products (HCPCS Q41xx-Q42xx and A20xx), wound-covering products billed per square centimetre, drew $235.2 million (235,247,923) on dermatologists' lines, billed by 274 dermatologists (our calculation). Radiation oncology codes (HCPCS 77261-77799 and G6001-G6017), which include superficial radiation treatment delivery (HCPCS 77401), drew $150.5 million (150,525,642), billed by 460 dermatologists (our calculation from CMS's provider-and-service file, which suppresses lines with fewer than 11 beneficiaries).

What do dermatologists bill Medicare for most?

Destroying premalignant skin lesions, such as actinic keratoses, is what dermatologists billed most often in 2024. Destruction of lesions 2 to 14 (HCPCS 17003, billed per lesion) came to 12.7 million services (12,701,462) on dermatologists' lines, and destruction of a first lesion (HCPCS 17000) to 4.0 million services (3,957,805), for which Medicare paid $149.3 million (149,305,828) (our calculation from CMS's provider-and-service file). 10,999 dermatologists billed 17000 in an office setting to 11 or more beneficiaries (CMS).

Low-complexity established-patient office visits (HCPCS 99213) are the biggest code by payment: 6.0 million services (6,024,216) and $372.6 million (372,552,650) in 2024 (our calculation). First-stage Mohs surgery on the head, neck, hands, feet or genitals (HCPCS 17311) comes second by payment: 747,328 services and $335.8 million (335,766,571) (our calculation). Tangential skin biopsies of a first lesion (HCPCS 11102) came to 2.2 million services (2,205,833) and $141.0 million (141,012,195) (our calculation), billed in an office setting by 10,641 dermatologists (CMS).

Who performs Medicare's Mohs surgery and skin biopsies?

Dermatologists and Mohs surgeons performed at least 98.4% of the 895,107 office-setting first-stage Mohs services (HCPCS 17311) that Medicare Part B paid for in 2024 (CMS). The share is our calculation and a floor, because CMS hides small lines. Those services went to 688,280 beneficiaries (CMS) and were billed by 3,308 providers of all specialties (CMS), at an average Medicare payment of $456.81 per office service (CMS). Only 39,841 first-stage Mohs services were billed in a facility setting (CMS). 2,531 dermatologists (CMS) and 357 providers of the 'Micrographic Dermatologic Surgery' type (CMS) billed 17311 in an office setting to 11 or more beneficiaries. Across all Mohs codes (HCPCS 17311-17315), Medicare paid the two groups $677.7 million (677,743,716) (our calculation).

Mohs volume grew faster than the number of dermatologists. Office-setting 17311 services rose 15.0% from 778,096 in 2019 (CMS; our calculation), and the number of beneficiaries receiving them rose from 594,473 (CMS). Florida accounted for 13.0% of office-setting first-stage Mohs services in 2024 (our calculation): 116,669 services (CMS), up from 107,599 in 2019 (CMS).

Skin biopsies are shared with physician assistants and nurse practitioners. Medicare paid for 3.4 million office-setting tangential biopsies of a first lesion (HCPCS 11102) in 2024 (3,427,855) (CMS), for 2.7 million beneficiaries (2,678,017) (CMS), at an average Medicare payment of $60.57 per office service (CMS); another 63,283 were billed in a facility setting (CMS). Dermatologists performed at least 63.1% of the office services (our calculation). On all non-suppressed 11102 lines in CMS's provider-and-service file, physician assistants and nurse practitioners billed 33.5% of services (our calculation); the file does not say which of them work in dermatology practices. Office 11102 services rose 7.5% from 3.2 million (3,188,109) in 2019 (CMS; our calculation).

Medicare paid for 6.2 million office-setting destructions of a first premalignant lesion (HCPCS 17000) in 2024 (6,192,745) (CMS), 19.6 million services for lesions 2 to 14 (HCPCS 17003, 19,550,746) (CMS) and 843,541 services for 15 or more lesions (HCPCS 17004) (CMS), across all specialties. Dermatologists performed at least 62.7% of the 17000 office services (our calculation). Office 17000 services rose 4.8% from 5.9 million (5,908,339) in 2019 (CMS; our calculation).

How often does Medicare pay for reviewing a patient's photos or video?

Rarely. Medicare Part B paid for 3,478 office-setting remote evaluations of recorded video or images sent by an established patient (HCPCS G2010, a store-and-forward service) in 2024, across all specialties (CMS), billed by 299 providers (CMS). Only 10 dermatologists had a G2010 line covering 11 or more beneficiaries (CMS), and those lines held 9.6% of the national total (our calculation). The file has no field that marks telehealth, so live video visits billed under ordinary office-visit codes cannot be separated from in-person visits.

How many dermatologists bill Medicare in Palm Beach, Broward and Martin counties?

146 dermatologists with a Palm Beach County practice address billed Medicare Part B fee-for-service in 2024, 100 in Broward County and 12 in Martin County (our count from CMS's by Provider file, matching each ZIP code to a county with the Census Bureau's 2020 ZIP-county relationship file). The three counties hold 24.7% of Florida's dermatologists billing Medicare (our calculation). Miami-Dade has 144 (our count). A dermatologist with offices in two counties appears once, at the address CMS lists.

Palm Beach County stands out. Medicare paid its dermatologists $66.7 million (66,724,502) in 2024, more than Broward and Miami-Dade dermatologists combined, although Miami-Dade has about as many dermatologists (our calculation). The number of Palm Beach dermatologists billing Medicare rose from 126 in 2019 to 146 in 2024, while Broward's fell from 105 to 100 (our count).

How many dermatologists work in the U.S.?

Dermatologists held about 12,200 U.S. jobs in 2025, counting the self-employed, according to the Bureau of Labor Statistics’ Occupational Outlook Handbook (BLS). BLS’s Occupational Employment and Wage Statistics (OEWS) survey of employers counted 11,370 wage and salary dermatologist jobs in May 2025 (BLS); that survey leaves out dermatologists who own unincorporated practices and pay themselves from profits. BLS’s Employment Projections put the self-employed share of dermatologist jobs at 4.0% in 2025 (BLS). Owners of incorporated practices who draw a salary count as wage and salary workers.

In May 2023 OEWS counted 12,040 wage and salary dermatologist jobs (BLS). BLS advises against comparing OEWS estimates across years, so the two counts are not a trend.

How much do dermatologists earn?

The median annual wage for U.S. wage and salary dermatologists was $328,730 in May 2025, per BLS OEWS (BLS). The mean was $323,530 (BLS). The median was 6.4 times the $50,980 median for all U.S. occupations (BLS) (our calculation). These figures cover wages and salaries only, not practice owners’ profits.

Pay is spread wide. One in ten wage and salary dermatologists earned less than $102,810 a year in May 2025 (BLS), and one in ten earned more than $578,560 (BLS).

Earlier BLS tables could not show the top of that range. For May 2023, BLS printed no median, 75th or 90th percentile wage for dermatologists: those cells carried its top-code footnote, meaning the wage was at least $239,200 a year (BLS). The May 2025 estimates print those percentiles as values.

Where do dermatologists work?

Offices of physicians (NAICS 6211) employed 10,170 wage and salary dermatologists in May 2025, per BLS OEWS (BLS): 89.4% of the national total (our calculation). Their median annual wage in physician offices was $331,380 (BLS). BLS has no separate industry for dermatology practices; they are counted inside offices of physicians, the shared industry described in the next section. Skincare specialists and med spas are covered on our aesthetics video statistics page.

How many dermatologists work in Florida and South Florida, and what do they earn?

BLS published no May 2025 OEWS estimate of dermatologist jobs or wages for Florida, for the Miami-Fort Lauderdale-West Palm Beach metro area (which holds Palm Beach and Broward counties) or for the Port St. Lucie metro area (which holds Martin County): the BLS data API lists no dermatologist series for any of the three areas.

The newest Florida figure is from May 2023, when OEWS estimated 2,000 wage and salary dermatologist jobs in the state, with a relative standard error of 44.7% and no wage estimates released (BLS). That was 16.6% of the U.S. count that year (our calculation), but the error margin is wide, so treat it as rough. BLS’s May 2023 tables for the two South Florida metro areas list no dermatologist row at all.

How fast is dermatologist employment expected to grow?

BLS projects dermatologist employment to grow 6.8% from 2025 to 2035, per its Employment Projections (BLS), against 3.5% for all occupations (BLS): 1.9 times as fast (our calculation). The Occupational Outlook Handbook puts that at 13,000 dermatologist jobs in 2035, up 800 from 12,200 in 2025 (BLS). BLS expects about 0.4 thousand openings for dermatologists each year over the decade, from growth and from replacing dermatologists who retire or leave the occupation (BLS).

How many physician offices are there in the U.S.?

Dermatology practices are counted inside offices of physicians (NAICS 621111), an industry shared with every physician specialty except mental health specialists such as psychiatrists, so every figure in this section covers all physician offices, not dermatology alone. BLS’s Quarterly Census of Employment and Wages (QCEW), which counts employers covered by unemployment insurance, averaged 226,698 private physician offices in the U.S. in 2025 (BLS), up from 204,988 in 2019 (BLS): a rise of 10.6% (our calculation).

Those offices employed an average of 2.9 million people (2,904,306) in 2025 (BLS), against 2.6 million (2,613,645) in 2019 (BLS): 11.1% more (our calculation). Average annual pay across all jobs in physician offices, from front desk to physician, was $116,597 in 2025 (BLS).

The Census Bureau’s County Business Patterns counted 204,617 employer physician offices in 2023, with 2.7 million employees (2,706,297) in mid-March (Census). Census’s Nonemployer Statistics counted another 186,842 physician-office businesses with no paid staff in 2023 (Census), so nonemployers were 47.7% of the physician-office businesses Census counted that year (our calculation). A nonemployer is any business with no paid employees and at least $1,000 in receipts, so the count is not a count of full-time practices. Nonemployer Statistics counted 190,427 such businesses in 2024, with receipts of $19,101,964 thousand (Census).

How much revenue do physician offices earn, and who pays?

U.S. employer offices of physicians (NAICS 621111) had receipts of $630,209,309 thousand (about $630 billion) in 2022 across 201,360 establishments, per the 2022 Economic Census, the Census Bureau’s full count of businesses every five years (Census). In 2017 the same industry took in $469,831,615 thousand (Census), so receipts rose 34.1% in five years before inflation (our calculation).

The Economic Census publishes no dermatology line. It splits physician-office receipts by the patient’s primary diagnosis, and diseases of the skin and subcutaneous tissue (ICD-10 L00-L99) made up 6.3% of receipts in 2022: $39,553,577 thousand, reported by 117,197 offices (Census). Many specialties treat skin conditions, and skin cancers are coded under neoplasms, a separate chapter, so this is not a measure of dermatology revenue.

Census publishes revenue by payer only for all physician offices (NAICS 6211, which also includes psychiatrists’ offices). Of their $640,432,147 thousand in 2022 receipts (Census):

How many physician offices earn money from telemedicine?

86,466 of the 201,360 U.S. employer offices of physicians (NAICS 621111) reported some revenue from telemedicine services in 2022, per the 2022 Economic Census (Census): 42.9% of them (our calculation). The table counts offices with any telemedicine revenue; it does not say how much of their revenue came from it, and it does not break out dermatology.

How much do physician offices spend on advertising?

U.S. offices of physicians (NAICS 6211, all specialties) spent $1,815,721 thousand, about $1.8 billion, on advertising and promotion in 2024, per the Census Bureau’s Annual Integrated Economic Survey (Census). That was 0.28% of their $652,560,160 thousand in total operating expenses (our calculation). Census does not publish advertising spending for dermatology practices or for NAICS 621111 on its own.

How many physician offices are there in Florida and in Palm Beach, Broward and Martin counties?

Florida averaged 21,918 private physician offices (NAICS 621111, all specialties) in 2025, per BLS’s QCEW (BLS), up 12.9% from 19,407 in 2019 (BLS) (our calculation). That was 9.7% of the U.S. total (our calculation). Florida’s physician offices employed an average of 252,530 people in 2025 (BLS). County Business Patterns counted 19,994 employer physician offices in Florida in 2023 (Census), and Nonemployer Statistics counted 19,222 physician-office businesses with no paid staff in 2024 (Census).

Together the three counties averaged 4,556 private physician offices in 2025, up 7.4% from 2019 and 20.8% of Florida’s total (our calculation). Per resident, Palm Beach County had 138.3 private physician offices per 100,000 residents in 2025 and Broward 110.3, against 93.4 for Florida and 66.3 for the U.S. (our calculation from QCEW 2025 annual averages and Census estimates of 23.5 million Floridians (23,462,518) (Census) and 341.8 million U.S. residents (341,784,857) (Census) on July 1, 2025). Martin County’s 93.2 was close to the state rate.

County Business Patterns counts offices with any paid employee in March; QCEW averages the offices covered by unemployment insurance over the year, so the two counts differ. Neither BLS nor Census publishes a county count of dermatology practices.

How many Americans get melanoma each year?

The American Cancer Society projects 112,000 new cases of invasive melanoma of the skin in the United States in 2026, and NCI’s SEER program prints that projection on its melanoma fact sheet (NCI SEER). The same projection puts melanoma deaths in 2026 at 8,510 (NCI SEER). The American Cancer Society, a nonprofit, also expects 122,680 cases of melanoma in situ in 2026, the earliest stage, which is not counted in the invasive total (American Cancer Society, Cancer Facts & Figures 2026).

Measured rather than projected, SEER’s registries counted 22.3 new melanoma cases per 100,000 men and women a year in 2019–2023, age-adjusted (NCI SEER). The U.S. melanoma death rate was 2.0 per 100,000 a year in 2020–2024 (NCI SEER). About 1.6 million people (1,573,288) were living in the United States in 2023 after a melanoma diagnosis, by SEER’s estimate (NCI SEER). The median age at diagnosis is 67, from SEER 21 cases diagnosed in 2019–2023 (NCI SEER).

SEER puts the lifetime risk of a melanoma diagnosis at about 2.2 percent for U.S. men and women of all races, based on 2021–2023 data (NCI SEER). Risk differs by skin color and sex. The American Cancer Society’s 2026 tables put the birth-to-death probability for non-Hispanic White men at 3.5% (1 in 28), using 2019–2022 data (American Cancer Society), and its consumer page gives about 3% (1 in 33) for White people overall, with far lower risk for Black and Hispanic people (American Cancer Society). These figures cover melanoma only. The popular “1 in 5 Americans will develop skin cancer” line counts all skin cancers, including the basal and squamous cell cancers below; our origins section traces where it comes from.

Is melanoma becoming more common, and are deaths falling?

New melanoma diagnoses have risen since the 1970s, while deaths have fallen over the past decade. In SEER’s original eight registry areas, the age-adjusted rate of new cases was 8.80 per 100,000 in 1975 (NCI SEER) and 28.26 in 2023 (NCI SEER), a rise of 221% (our calculation). SEER’s trend model has rates rising an average 1.1% a year over 2014–2023 (NCI SEER). Registry counts record diagnoses, not their causes, so they cannot separate more disease from more skin checks and biopsies.

Deaths moved the other way. SEER’s model has age-adjusted melanoma death rates falling an average 2.2% a year over 2015–2024 (NCI SEER). The American Cancer Society credits major advances in treating advanced disease: five-year relative survival for melanoma that has spread to distant organs was 15% in the mid-2000s, against SEER’s current 34.0% (American Cancer Society).

How many people survive melanoma, by stage at diagnosis?

94.7% of people diagnosed with melanoma of the skin in 2016–2022 were alive five years later relative to people without melanoma, according to SEER (NCI SEER). Stage at diagnosis drives the gap: SEER reports that 76.9% of melanomas are found at the localized stage, before they spread (NCI SEER). Relative survival describes large groups, not any one patient.

How many basal and squamous cell skin cancers are diagnosed?

No registry counts them, so the best national figure is a model: Rogers and colleagues estimated about 5.4 million basal and squamous cell skin cancers (5,434,193) in the U.S. population in 2012 (Rogers et al., JAMA Dermatology, 2015), in about 3.3 million people (3,315,554) (Rogers et al., JAMA Dermatology, 2015). They built it from Medicare claims for skin cancer procedures and national office-visit survey data. These cancers are also called keratinocyte carcinomas; the American Cancer Society says deaths from them are very rare.

That 2012 estimate is still the one cited in 2026. The American Cancer Society’s basal cell page says about 5.4 million are diagnosed each year, citing the Rogers study (American Cancer Society). Its Cancer Facts & Figures 2026 rounds to more than 5 million a year and notes the actual number is unknown (American Cancer Society). Against that total, invasive melanoma is about 1% of all skin cancer cases but causes most skin cancer deaths (American Cancer Society).

What does skin cancer treatment cost in the United States?

About 6.1 million U.S. adults were treated for skin cancer each year in 2016–2018, according to a CDC analysis of the Medical Expenditure Panel Survey by Kao and colleagues (Kao et al., Cancer Causes & Control, 2023). Treatment cost $8.9 billion a year in that period (Kao et al., Cancer Causes & Control, 2023). An earlier CDC, AHRQ and NCI study using the same survey found an average $8.1 billion a year in 2007–2011 (Guy et al., American Journal of Preventive Medicine, 2015). Both studies count melanoma and non-melanoma skin cancer together.

CDC’s own skin cancer statistics page describes the same numbers differently: it says about 6.1 million adults are treated each year for basal and squamous cell carcinomas, at the same cost (CDC, via Internet Archive). The study it draws on reports those figures for all skin cancers, melanoma included, so this page follows the study.

How common are other skin diseases?

Nearly 85 million Americans saw a physician for at least one skin disease in 2013, according to the American Academy of Dermatology’s burden of skin disease study, which analysed 2013 insurance claims across 24 disease categories (Lim et al., Journal of the American Academy of Dermatology, 2017). The same study put direct health care costs for skin disease at $75 billion that year (Lim et al., Journal of the American Academy of Dermatology, 2017). The AAD is the dermatologists’ professional association.

• Psoriasis: 3.0% of U.S. adults aged 20 and older reported a psoriasis diagnosis in the 2011–2014 National Health and Nutrition Examination Survey (12,625 participants) (Armstrong et al., JAMA Dermatology, 2021). Applied to the 2020 Census, that is an estimated 7.55 million adults (Armstrong et al., JAMA Dermatology, 2021). Co-authors came from the National Psoriasis Foundation and a dermatology software company.
• Atopic dermatitis (eczema): 7.3% of 1,278 U.S. adults in the Atopic Dermatitis in America survey had the condition (Chiesa Fuxench et al., Journal of Investigative Dermatology, 2019), which the authors projected to 16.5 million U.S. adults (Chiesa Fuxench et al., Journal of Investigative Dermatology, 2019).
• Acne: in a survey of 1,013 adults on one Alabama university campus and medical complex, 50.9% of women aged 20–29 said they had acne (Collier et al., Journal of the American Academy of Dermatology, 2008). It is self-reported and local; we found no newer national U.S. acne prevalence study with a published abstract.

How often do Americans get sunburned, wear sunscreen or tan indoors?

35.1% of U.S. adults had at least one sunburn in the previous 12 months in 2024, according to CDC’s analysis of the National Health Interview Survey (CDC, MMWR, 2026). Among adults who were burned, 55.1% said their most recent sunburn happened even though they had used sunscreen (CDC, MMWR, 2026). An earlier version of the same survey, with different questions, found 29.1% of adults sunburned in 2020 (NCI Cancer Trends Progress Report), so the two years are not a trend.

In that 2020 survey, 36.5% of adults said they always or most of the time used sunscreen of SPF 15 or higher when outside on a sunny day for more than an hour (NCI Cancer Trends Progress Report). Teenagers burn more often: 64.4% of U.S. high school students were sunburned in the past year in 2021, from CDC’s Youth Risk Behavior Survey (NCI Cancer Trends Progress Report).

Indoor tanning among teenagers has fallen sharply. The share of U.S. high school students who used a tanning bed or booth in the past year went from 15.6 to 5.6% between 2009 and 2017, according to CDC researchers using the Youth Risk Behavior Survey (Holman et al., Journal of Community Health, 2019). It was 4.5% in 2019, the latest year reported (NCI Cancer Trends Progress Report). The rules on tanning beds for minors are in our rules section.

How much melanoma is there in Florida and in Palm Beach, Broward and Martin counties?

The American Cancer Society projects 10,530 new invasive melanoma cases in Florida in 2026 (American Cancer Society, Cancer Facts & Figures 2026), 9.4% of the U.S. total and second among states only to California (our calculation). Florida’s Department of Health, using the Florida Cancer Data System, counted 9,415 new melanoma cases in 2023 (Florida Department of Health), an age-adjusted rate of 28.5 per 100,000 (Florida Department of Health), up from 17.6 in 2005 (Florida Department of Health). Florida’s method differs from SEER’s, so the state rate and the national SEER rate should be compared only loosely.

Martin County’s 2023 rate was 1.97 times the statewide rate (our calculation). It is a small county, so its single-year rate swings from year to year. Broward’s rate was well below the state’s. 690 Florida residents died of melanoma in 2025, the latest year in the state’s death records (Florida Department of Health). In Florida’s 2025 Behavioral Risk Factor Surveillance System survey, 8.8% of adults said a health professional had ever told them they had skin cancer of any type (Florida Department of Health).

Do listed dermatology companies tell investors about video?

None of the 11 newest annual reports (Form 10-K) we read from companies that sell to dermatologists used the word "video": Castle Biosciences, Sensus Healthcare, Arcutis, Verrica, Journey Medical, STRATA Skin Sciences, Biofrontera, Incyte and AbbVie for fiscal 2025, and DermTech and Cutera for fiscal 2023, their last (our calculation from the filings on SEC EDGAR). Of the 9 dermatology-focused companies in that set, 3 describe using social media to reach patients, and only DermTech mentions telemedicine (our calculation). Annual reports describe channels in broad terms, so the absence of the word does not mean the companies make no videos.

The social media lines are specific. STRATA Skin Sciences says it runs direct-to-patient XTRAC laser advertising for psoriasis and vitiligo, including on Facebook and X, to reach the more than 10 million U.S. patients it believes have these diseases (STRATA 10-K for fiscal 2025). Verrica says consumer marketing for its molluscum treatment YCANTH runs through social media and print advertising, while doctors get peer-to-peer education and data-driven digital advertising (Verrica 10-K for fiscal 2025). Bausch Health's cash-pay program for select dermatology brands lets patients choose telemedicine, home delivery or a pharmacy, and is meant to connect them with dermatologists (Bausch Health 10-K for fiscal 2025). DermTech, which offered at-home sampling during telemedicine visits, called the telemedicine market relatively new and unproven, especially within dermatology (DermTech 10-K for fiscal 2023).

How many skin cancer gene tests does Castle Biosciences run?

Castle Biosciences delivered 39,083 DecisionDx-Melanoma test reports in 2025, up from 20,328 in 2021, according to its fiscal 2025 Form 10-K (Castle 10-K). Clinicians order it for patients diagnosed with invasive melanoma. Its squamous cell carcinoma test, DecisionDx-SCC, reached 17,294 reports, up from 3,510 in 2021 (Castle 10-K). All dermatologic tests together came to 60,665 reports in 2025 (Castle 10-K), 128.9% more than in 2021 (our calculation). Dermatologic volume grew 7.8% in 2025 (Castle 10-K).

Revenue went the other way. Castle's revenue from dermatologic tests fell $40.6 million in 2025, mainly because DecisionDx-SCC lost its Medicare local coverage on April 24, 2025 (Castle 10-K). Non-dermatologic tests rose to 37.1% of net revenue (Castle 10-K), which leaves dermatology at about 62.9%, down from 77.4% in 2024 (our calculation). Castle spent $138.1 million ($138,115 thousand) on sales and marketing in 2025, mostly people, training events, speaker conferences and sales travel (Castle 10-K).

Castle sizes its markets with its own estimates. It puts invasive cutaneous melanoma at about 130,000 U.S. patients in a typical year, a figure it adjusts upward from SEER registry counts for underreporting (Castle 10-K for fiscal 2025). It says about two million suspicious pigmented lesions are biopsied in the U.S. each year, of which about 300,000 are difficult to diagnose (Castle 10-K for fiscal 2025).

How many Sensus Healthcare skin cancer radiation systems are in use?

Sensus Healthcare, based in Boca Raton in Palm Beach County, had installed 955 superficial radiation therapy (SRT) units in 21 countries, mostly in the United States, by the end of 2025, according to its Form 10-K (Sensus 10-K). The SRT-100 treats non-melanoma skin cancer and keloids; Sensus sells it to dermatology practices and radiation oncologists and says it lets dermatologists keep these patients instead of referring them. It sold 70 units in 2025, against 115 in 2024 (Sensus 10-K), a drop of 39.1% (our calculation).

Revenue fell to $27.5 million in 2025, down 34% (Sensus 10-K). One U.S. customer, not named in the filing, accounted for 52% of revenue in 2025 and 73% in 2024 (Sensus 10-K). Sensus spent $2.0 million on advertising and promotion in 2025 (Sensus 10-K), 7.3% of revenue (our calculation), and $6.5 million on selling and marketing, up 30% on tradeshow costs and sales headcount (Sensus 10-K).

How many sales reps call on dermatologists?

Verrica had about 40 field sales representatives at the end of 2025, calling on pediatric dermatologists, dermatologists, pediatricians and some primary care providers (Verrica 10-K). It plans to grow to 50 in 2026 (Verrica 10-K), after cutting 47 jobs in October 2024 and shrinking from 80 sales territories to about 35 (Verrica 10-K). DermTech sold its melanoma test to dermatology clinicians with about 55 sales representatives (DermTech 10-K) and had 81 of its 208 employees in sales and marketing at the end of 2023 (DermTech 10-K).

Journey Medical had 58 full-time employees in March 2026, 39 of them in sales and marketing (Journey 10-K). It says that outreach covers over 80% of dermatologists in the 50 largest U.S. metro areas and over 70% of the dermatology prescribing market (Journey 10-K). STRATA Skin Sciences had 44 sales and marketing staff among 114 employees (STRATA 10-K for fiscal 2025) and names its target audience as about 3,500 U.S. dermatologists who perform disease management (STRATA 10-K for fiscal 2025). Arcutis describes a focused specialty sales force targeting dermatologists and allergists, and after ending its primary-care promotion deal with Kowa in January 2026 it plans a small team for high-prescribing primary care and pediatric offices (Arcutis 10-K).

How much do dermatology companies spend on advertising?

Of the dermatology-only companies that report advertising costs, Arcutis spent the most: $25.3 million in 2025, against $6.9 million in 2024 (Arcutis 10-K): 3.7 times as much (our calculation), and 6.8% of its ZORYVE net product revenue (our calculation). Incyte, whose dermatology product is OPZELURA cream, spent about $155.9 million on advertising in 2025, mostly television, radio, print and internet, but that figure covers all of its products (Incyte 10-K).

What do the filings say about dermatology patients and prescriptions?

Arcutis estimates that 8.4 million U.S. patients on prescription topicals for psoriasis, seborrheic dermatitis and atopic dermatitis are treated in dermatology offices, out of 17.0 million in all (Arcutis 10-K for fiscal 2025), or 49.4% (our calculation). Of those dermatology-office patients, it estimates 3.7 million are covered by Medicare or Medicaid and 4.7 million by private insurers (Arcutis 10-K for fiscal 2025). These are company estimates from market research.

Journey Medical's 10-K cites prescription data from Symphony Health, a commercial data vendor: the U.S. topical acne market had more than 24.8 million prescriptions in 2025 (Journey 10-K), oral isotretinoin just over 2.3 million (Journey 10-K) and topical rosacea more than 4.7 million (Journey 10-K). Verrica estimates about 6 million people in the U.S. have molluscum contagiosum, with about 1 million diagnosed each year (Verrica 10-K).

STRATA Skin Sciences had 842 XTRAC excimer lasers placed in U.S. dermatologists' offices at the end of 2025, down from 864 (STRATA 10-K). STRATA estimates they delivered about 251,000 treatments in 2025 at $65 to $100 each (STRATA 10-K), about 298 per placed laser (our calculation). It also had 166 TheraClear acne devices in dermatologists' offices, up from 144 (STRATA 10-K).

How much do dermatology drugs and devices sell?

Incyte's OPZELURA cream for atopic dermatitis and vitiligo brought in $678.5 million in 2025, up from $508.3 million (Incyte 10-K). Arcutis's ZORYVE products reached $372.1 million ($372,072 thousand), up 123% (Arcutis 10-K). AbbVie's Skyrizi had $17,562 million in net revenues, but that covers psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis together (AbbVie 10-K).

Companies that sell only dermatology products are much smaller. Journey Medical's revenues were $61.2 million in 2025 (Journey 10-K), Biofrontera's product revenues (Ameluz photodynamic therapy for actinic keratosis) $41.7 million ($41,705 thousand) (Biofrontera 10-K) and Verrica's YCANTH $15.3 million (Verrica 10-K).

Which dermatology companies went bankrupt?

DermTech, which sold a non-invasive patch test for melanoma, filed for Chapter 11 on June 18, 2024 and planned to sell substantially all its assets (DermTech 8-K). In its last 10-K it reported about 66,540 billable samples in 2023, down from about 68,230 (DermTech 10-K), and said that historically less than one third of billable samples had been reimbursed (DermTech 10-K).

Cutera, a maker of aesthetic lasers, filed for Chapter 11 on March 5, 2025 (Cutera 8-K). Its AviClear acne laser reached over 1,200 devices on a lease model, but Cutera said its key customers, aesthetic dermatologists, wanted to own the machines, and it paused new leases in August 2023 (Cutera 10-K). The aesthetics statistics page covers Cutera's advertising.

How often do annual reports mention dermatologists?

35 Form 10-K annual reports filed in 2025 contained the word "dermatologist" or "dermatologists", against 24 in 2001 and a peak of 51 in 2015, 2018, 2020 and 2021 (our calculation from SEC EDGAR full-text search). From 2001 to 2025, 1,017 10-Ks by 251 companies used either word (our calculation). The word "dermatology" appeared in 133 10-Ks filed in 2025, against 42 in 2001 and a peak of 163 in 2022 (our calculation).

We read all 35 filings from 2025 to see what drives the count. 22 come from companies whose market runs through dermatologists (drugs, devices, tests and services), 7 use the word in consumer product claims such as "dermatologist-tested", and 6 mention one in passing (our calculation). No boilerplate list inflates it, unlike "podiatrists", which drug makers' Sunshine Act disclosures repeat. The phrase "dermatology practice" or "dermatology practices" appeared in only 3 10-Ks filed in 2025 (our calculation).

Video and remote care barely register. From 2001 to 2025, 88 10-Ks by 42 companies contained both "dermatologist" (or "dermatologists") and "video"; in 2025 just 1 did, and there "video" referred to the Video Privacy Protection Act (our calculation). In most of the older filings "video" meant video conferencing, imaging equipment or a cable network, not patient video. 10-Ks that pair a dermatologist with "telehealth" or "telemedicine", or use "teledermatology", rose from 2 filed in 2019 to 13 in 2022 and fell to 4 in 2025 (our calculation). Only 11 10-Ks from 2001 to 2025, by 5 companies, used the word "teledermatology"; none did in 2025 (our calculation). The yearly counts, filer names and query links are in our EDGAR counts file, and the 2025 filings with the text of each mention are in our 2025 contexts file.

What do lenders' filings show about dermatology practice groups?

17 Form 10-Ks filed in 2025 by business development companies and private credit funds contained "dermatology", against 0 in 2001; 16 of them list loans to 8 dermatology practice groups, and 1 lists a veterinary dermatology group (our calculation from SEC EDGAR full-text search and each fund's schedule of investments). Private dermatology groups file no annual reports, but these lenders do, and their filings name the groups.

The schedules show the size and condition of individual loans. At the end of 2025, FS KKR Capital held a first-lien loan to Advanced Dermatology & Cosmetic Surgery with $44.9 million in principal, due May 2027 and carried at full value (FS KKR 10-K). Nuveen Churchill Direct Lending held $3,282 thousand (par) of 12.75% payment-in-kind subordinated debt of Anne Arundel Dermatology Management, carried at a fair value of $1,180 thousand (Nuveen Churchill 10-K).

What may a sunscreen label or sunscreen ad claim under FDA rules?

Under FDA’s sunscreen labeling rule, as in force in November 2026, a sunscreen may claim water resistance for 40 minutes (eCFR, 21 CFR 201.327) or 80 minutes (eCFR), each proved in a water-immersion test on volunteers, and no other time. Only broad spectrum products with an SPF of 15 or higher may say they lower the risk of skin cancer and early skin aging, and only when used with other sun protection measures (eCFR). Lower-SPF products, and products that fail the broad spectrum test, must open their warnings with a “Skin Cancer/Skin Aging Alert” saying they help prevent sunburn only (eCFR). Labels must tell users to reapply at least every 2 hours (eCFR).

The same FDA rule names “sunblock”, “sweatproof” and “waterproof” as false or misleading claims (eCFR), and any labeling or promotional material suggesting that sunscreen used alone prevents skin cancer or early skin aging makes the product misbranded (eCFR). So a sunscreen video that talks about skin cancer has to present sunscreen as one sun protection measure among others. Every labeled SPF number comes from a test dose of 2 milligrams per square centimeter of skin (eCFR); the myths section covers what that dose assumes. This section summarizes published rules; it is not legal or medical advice.

Where does FDA’s sunscreen rulemaking stand in 2026?

FDA issued two orders changing the list of sunscreen ingredients in 2026: in June it added bemotrizinol, the first new active ingredient in the over-the-counter sunscreen monograph since the late 1990s (FDA), and on September 10, 2026 it issued a final order removing PABA and trolamine salicylate, saying their risks outweigh their benefits (FDA). The current rules date from the CARES Act, which turned the old sunscreen monograph into a “deemed final order” on March 27, 2020 (FDA); that order allowed sunscreens made with any of 16 active ingredients (FDA).

FDA’s February 2019 proposed sunscreen rule would cap the labeled SPF at SPF 60+ (Federal Register) and proposed only zinc oxide and titanium dioxide, at concentrations up to 25 percent, as generally recognized as safe and effective (Federal Register). FDA moved those proposals into a 2021 proposed order, which drew over 15,000 public comments (FDA). As of FDA’s September 2026 update, the SPF cap, the label changes and the status of the other chemical filters were still not final.

What do federal and Florida rules say about indoor tanning?

Since FDA’s reclassification took effect on September 2, 2014 (Federal Register), tanning beds and booths have been Class II medical devices (eCFR, 21 CFR 878.4635). Each must carry a black-box warning that it should not be used on anyone under 18 years of age (eCFR), and makers must warn that people who have had skin cancer or have a family history of skin cancer should not use them (eCFR). FDA withdrew its proposal to bar minors from tanning beds outright on March 16, 2026 (Federal Register), so the federal rule stays a warning, not a ban. Federal law taxes indoor tanning at 10 percent of the price (26 U.S.C. 5000B) for services from July 1, 2010 (26 U.S.C. 5000B), but the tax does not apply to a phototherapy service performed by a licensed medical professional, such as UV treatment in a dermatology office (26 U.S.C. 5000B).

Florida’s tanning law (Florida Statutes 381.89, 2026) lets a minor between the ages of 14 and 18 tan only if a statement signed by a parent or guardian is on file (Florida Statutes 381.89), and a minor under the age of 14 must be accompanied by a parent or guardian (Florida Statutes 381.89). A Florida tanning salon may not claim, in person or in promotional materials, that a device is “safe or free from risk” (Florida Statutes 381.89), and the Department of Health may fine a salon up to $1,000 per violation per day (Florida Statutes 381.89).

What must a Florida dermatologist’s ad or video include, and what is banned?

The Florida Board of Medicine’s advertising rule, in the version effective 3/19/2026 (Florida Administrative Code 64B8-11.001), requires a physician who advertises on electronic media to keep an exact copy of each audio or video ad for at least six months after it airs (Florida Administrative Code 64B8-11.001). The rule treats an ad as false, deceptive or misleading if it creates false or “unjustified expectations of beneficial assistance” (Florida Administrative Code 64B8-11.001). Florida’s physician statute lists “False, deceptive, or misleading advertising” as grounds for discipline (Florida Statutes 458.331), the Board may fine up to $10,000 for each count (Florida Statutes 456.072), and any ad naming a practitioner must identify the type of license that person holds (Florida Statutes 456.072), which applies when practice videos feature physician assistants or nurse practitioners.

A Florida physician may advertise as board-certified only with recognition from a board of the American Board of Medical Specialties or another agency the Board of Medicine has approved (Florida Statutes 458.3312). A physician who cites recognition from an unapproved board must add, in the same print size or volume, that it came from a “private organization not affiliated with or recognized by the Florida Board of Medicine” (Florida Administrative Code 64B8-11.001). An ad for a free or discounted service, such as a free skin check, must state in capital letters that the patient may refuse to pay for any other service performed as a result of, and within 72 hours of, responding to the ad (Florida Statutes 456.062).

Since 2020, Florida law has “expressly preempted to the state” the regulation of over-the-counter drugs and cosmetics, sunscreen included (Florida Statutes 499.002). The Florida Senate’s staff analysis of that bill traces it to a Key West ordinance, passed in February 2019, that banned selling sunscreens containing oxybenzone or octinoxate without a prescription (Florida Senate bill analysis).

What do Florida law and Medicare allow for teledermatology?

Florida’s telehealth statute (Florida Statutes 456.47, 2026) covers “synchronous or asynchronous” technology (Florida Statutes 456.47), so both live video visits and store-and-forward photo review count, while e-mail and fax do not. A Florida provider whose remote evaluation is enough to diagnose and treat does not have to do a physical examination first (Florida Statutes 456.47), and medical records from telehealth visits, including video, are confidential (Florida Statutes 456.47).

For Medicare patients, CMS’s Telehealth FAQ (updated October 2026) says telehealth can be received anywhere in the United States, including at home, through December 31, 2027 (CMS). After that date, unless Congress extends it, most Medicare patients outside behavioral health will need to be in a medical facility in a rural area for a visit to count as telehealth (CMS).

What do FTC rules say about dermatologist endorsements, testimonials and health claims?

The FTC’s Endorsement Guides, revised on July 26, 2023 (eCFR, 16 CFR Part 255), use a dermatologist as their own example of an expert endorser: a paid advisor to a drug company who posts on a professional account that its new acne treatment is “clinically proven” is liable if they should have seen that the study was too flawed to support the claim (eCFR). The company and the dermatologist are both potentially liable if the paid relationship is not disclosed, even when the study is sound (eCFR).

The same FTC Guides read a patient testimonial as typical, so an ad that cannot back that up should disclose the generally expected performance (eCFR, 16 CFR 255.2(b)). Stock photos of people with “near perfect skin” beside acne testimonials misrepresent the results (eCFR). When a video makes a claim in both pictures and sound, the disclosure belongs in both the visual and audible portions (eCFR). The FTC’s separate rule on fake reviews and testimonials took effect on October 21, 2024 (Federal Register).

FTC staff’s Health Products Compliance Guidance (December 2022) says health-benefit claims generally need randomized, controlled human clinical testing behind them (FTC, archived copy). In its example of an acne app sold with a “renowned dermatologist” claim, a same-size disclaimer that the app is for entertainment only is directly contradictory and does not cure the claim (FTC, archived copy). Under HIPAA, full face photographic images and comparable images are identifiers (eCFR, 45 CFR 164.514), so before-and-after photos and patient videos that show a face are identifiable health information.

What did CMS set for Medicare physician payment in 2027?

CMS’s CY 2027 Physician Fee Schedule final rule, issued in November 2026, sets the conversion factor for physicians outside qualifying alternative payment models at $32.63 (CMS), down from $33.40 in 2026 (CMS), because a one-year 2026 increase lapses. The rule also cuts payment when an office visit is billed on the same day, by the same physician, as a procedure with no post-operative global period, such as a skin biopsy: the less expensive of the two is paid at 80% (CMS). Medicare billing counts for dermatologists are in the Medicare data section above.

What do the popular dermatology numbers really say?

Dermatology practice websites, health news and marketing vendors repeat a handful of skin cancer and sunscreen numbers more than any others. Most come from two associations, the Skin Cancer Foundation (SCF) and the American Academy of Dermatology (AAD). We traced six of them to the study, press kit or vendor that produced them and read what each measured. Pages that repeat a number are linked only as dated evidence of how it spread, never as a source for the number itself.

“1 in 5 Americans will develop skin cancer by age 70”

The “by age 70” wording is a 2018 rewrite of a 1996 lifetime estimate, and the paper it now cites measured something narrower. In July 1994 a skin cancer fact list credited to AAD and the Arizona Cancer Center said one in 6 Americans will develop skin cancer in a lifetime, beside an estimate of over 700,000 new cases that year (Arizona Daily Wildcat). By 1996 an AAD press feature quoted New York University dermatologist Darrell Rigel: “One in five Americans will get a skin cancer of some kind in their lifetime”, next to more than 1 million new skin cancers expected that year (AAD, archived). Rigel, Robert Friedman and Alfred Kopf put the new figure in the title of a December 1996 letter in the Journal of the American Academy of Dermatology: “current estimate is now 1 in 5” (JAAD). PubMed holds no abstract for the letter and its publisher blocks AI agents, so we could not read how it was calculated.

SCF carried the lifetime form for years. Its January 2012 facts page said One in five Americans will develop skin cancer “in the course of a lifetime”, footnoted to a 2005 JAMA commentary (SCF, archived). Between the January 4 and February 8, 2018 captures the line became “by the age of 70” and the footnote changed to Robert Stern’s 2010 paper in the Archives of Dermatology (SCF, archived). Stern built a mathematical model from National Cancer Institute incidence data from 1977-1978, SEER and the 2007 National Health Interview Survey. Its headline count is of white non-Hispanic Americans: about 13 million alive at the start of 2007 had had at least one basal or squamous cell skin cancer (Archives of Dermatology). It also estimated that about 1 in 5 seventy-year-olds have had one (Archives of Dermatology). That is a modelled share of 70-year-olds who have already had a basal or squamous cell cancer. It is not a forecast for all Americans, and melanoma is not in it.

The two associations now attach different promises to the same paper. SCF’s live page says “at least one in five Americans will develop skin cancer by the age of 70” (SCF). AAD’s statistics page, updated March 2026, says one in five will develop it “in their lifetime”, footnoted to Stern (AAD).

Use instead: “A 2010 model estimated that about 1 in 5 Americans aged 70 have already had a basal or squamous cell skin cancer (Stern, Archives of Dermatology).” For melanoma, use the National Cancer Institute’s SEER lifetime risk in our skin cancer burden section.

“SPF 30 blocks 97% of UVB” (and SPF 15 93%, SPF 50 98%)

The percentages are arithmetic, not measurements, and they assume a lab dose few people apply. SPF compares the ultraviolet dose that just reddens skin with and without sunscreen, and the U.S. Food and Drug Administration’s test applies the product at 2 mg/cm² (Photodermatology, Photoimmunology & Photomedicine).

The earliest dated print we could read is AAD material from its 1997 annual meeting, reprinted by the San Diego Earth Times in August 1997: an SPF 30 “absorbs 97 percent of sunburning rays”, with a matching figure for SPF 15, “under ideal circumstances”, because people often do not apply a thick enough film (San Diego Earth Times). AAD’s 1998 press kit printed the pair again: “An SPF 15 absorbs 93% of the sun-burning rays, while an SPF 30 absorbs 97%” (AAD, archived). Neither cites a study. Each figure is the share of sunburning rays a layer stops if it lets through one part in the SPF number (one part in 30 for SPF 30), at the test dose. An SCF “Ask the Expert” answer by Steven Q. Wang, MD, captured in February 2012, added SPF 50 at 98 percent (SCF, archived). It also warned that most people apply only 0.5 to one milligram per square centimeter, below the test dose (SCF, archived). SCF’s June 2022 press release repeats the set, SPF 15 filtering out approximately 93 percent of UVB; it advises an ounce of sunscreen for the whole body but does not tie the percentages to the amount applied (SCF). AAD’s sunscreen FAQs, updated February 2025, say SPF 30 “blocks 97% of the sun’s UVB rays” (AAD).

Studies of real use find people apply a fraction of the test dose. Danish beachgoers who applied their own sunscreen used an average of 0.5 mg/cm² (Bech-Thomsen and Wulf, 1992) (Photodermatology, Photoimmunology & Photomedicine). European students aged 18 to 24, given SPF 10 or SPF 30 for their 1997-1998 summer holidays, used a median 0.39 mg/cm², whatever the SPF (Autier et al., British Journal of Dermatology, 2001) (British Journal of Dermatology). Beachgoers in Denmark applied a mean 0.57 mg/cm² (Heerfordt, Danish Medical Journal, 2018) (Danish Medical Journal), which the author calculated gave sunscreens with a median label of SPF 20 a mean effective SPF of 2.3 (Danish Medical Journal).

How far protection falls with a thin layer is disputed. In a small Copenhagen phototest study with an SPF 4 product, Faurschou and Wulf (2007) found protection grows exponentially with amount, so at a quarter of the test dose the SPF falls to its fourth root (British Journal of Dermatology). A 2012 lab study led by a scientist at Neutrogena, which sells high-SPF sunscreen, with Darrell Rigel as co-author, found a straight-line relation instead: a product labelled SPF 70 gave an actual SPF of 19 at a quarter of the test dose (JAAD). Either way, the label percentage describes the test, not the bottle on the beach.

Use instead: “At the test dose of 2 mg/cm², an SPF 30 sunscreen lets through about one part in 30 of sunburning UV. Studies of real use measured 0.39 to 0.57 mg/cm².” Present SPF percentages as lab arithmetic, with the dose.

“More people are diagnosed with skin cancer each year than all other cancers combined”

The claim began as a share of new cases and as a count of people living with a cancer history, and became a yearly diagnosis claim in 2018. AAD’s fact sheet, captured in December 1997 and citing American Cancer Society 1996 projections, said “Half of all new cancers are skin cancers” (AAD, archived). In January 2012 SCF wrote that over the past 31 years more people have had skin cancer than all other cancers combined (SCF, archived). That came from Stern’s 2010 model, which compared people living with a history of skin cancer with the 31-year prevalence of all other cancers combined (Archives of Dermatology): people who have ever had each cancer, not new diagnoses. In the same early-2018 rewrite that added “by the age of 70”, SCF’s line became “more people are diagnosed with skin cancer each year in the U.S. than all other cancers combined”, footnoted to the American Cancer Society’s Cancer Facts & Figures (SCF, archived). The live page keeps that wording. Squamous cell skin cancer is excluded from national cancer registries (JAAD), so any yearly comparison with all other cancers sets an estimate against registry counts.

Use instead: “A 2010 model estimated that more Americans are living with a history of skin cancer than with a history of all other cancers combined diagnosed over the past 31 years (Stern, Archives of Dermatology).” For yearly numbers, use the keratinocyte cancer estimate and the melanoma counts in our burden section, and call the first an estimate.

“Five or more sunburns doubles your risk of melanoma”

The study behind it says more than five, was European, and relied on memory. SCF’s January 2012 page said melanoma risk doubles with more than five sunburns “at any age” (SCF, archived), footnoted to Pfahlberg, Kölmel and Gefeller in the British Journal of Dermatology (2001). That case-control study interviewed melanoma patients and population controls in seven European countries about sunburns in childhood and adulthood, and found More than five sunburns doubled the risk, whatever their timing (British Journal of Dermatology). SCF’s live page header now says “Having 5 or more sunburns doubles your risk for melanoma”, while the body text of the same page still says more than five (SCF).

AAD cites a different study and threshold. Its statistics page says five or more blistering sunburns between ages 15 and 20 raise melanoma risk by 80% (AAD). That comes from the Nurses’ Health Study II, a cohort of U.S. women followed from 1989 to 2009, in which the relative risk for that group was 1.80 compared with no sunburns at those ages (Wu et al., Cancer Epidemiology, Biomarkers & Prevention, 2014) (Cancer Epidemiology, Biomarkers & Prevention).

Use instead: “In a 2001 European case-control study, more than five recalled sunburns doubled melanoma risk (Pfahlberg et al.). In a U.S. cohort of women, five or more blistering sunburns at ages 15 to 20 carried a relative risk of 1.80 (Wu et al., 2014).”

“Every hour, more than two people die of skin cancer”

The hourly figure started as one melanoma death an hour and doubled when SCF counted all skin cancers. AAD’s May 2, 1996 press release on a JAAD paper by Rigel, Friedman and Kopf said one person an hour dies from malignant melanoma (AAD, archived). An AAD feature the same year already widened it to “someone dies from skin cancer every hour” (AAD, archived). In January 2012 SCF put it at one melanoma death every hour, “every 62 minutes” (SCF, archived), and AAD’s statistics page in January 2019 still said one American dies from melanoma every hour (AAD, archived). By July 2019 SCF wrote that more than two people die of skin cancer every hour (SCF, archived).

Melanoma alone was about one death an hour in all of those versions, so two an hour needs estimated deaths from other skin cancers added in, including squamous cell carcinoma, which national cancer registries exclude. One modelling study put 2012 deaths from it among white Americans at 3,932 to 8,791 (Karia et al., JAAD, 2013) (JAAD), and its authors asked for population studies to check the range. SCF dropped the hourly line between its January 9 and January 17, 2026 captures, when the page moved to the 2026 American Cancer Society figures; it is not on the live page.

Use instead: the melanoma death counts from NCI and CDC in our burden section. If deaths from other skin cancers matter, give Karia’s range and call it a 2012 model estimate.

“Video on a landing page lifts conversions by 80%”

The figure is a best case from one video vendor, EyeView, in 2009-2010, about financial and tutoring websites, not healthcare. EyeView’s blog first reported that eToro visitors who watched its video were 20% more likely to download the product (December 2008) (EyeView, archived). In February 2009 it said UMOO viewers were 80% more likely to become depositing users, comparing viewers with non-viewers for one client (EyeView, archived), and in November 2009 it quoted a TutorVista manager on a first test that lifted conversion by over 80 percent (EyeView, archived). Its 2010 white paper said only that “in some cases” the boost was over 80% (EyeView white paper, archived), and the one test it described, the eToro split test, was now almost 32 percent (EyeView white paper, archived).

The scope fell away in repeats. By August 2010 Unbounce, a landing-page software seller, wrote that video on landing pages can increase conversion by 80% (Unbounce, archived), and WordStream, a pay-per-click software seller, repeated 80% in March 2016, crediting “EyeWideDigital” (WordStream). Healthcare marketing carried it on: Nucleus Medical Media listed 80% in 2018, credited to Eyeview Digital (Nucleus Medical Media), and Practice Builders, which markets medical and dental practices, wrote 80 percent in a 2018 white paper, crediting a different video producer (Practice Builders). It reached dermatology the same way. A September 2021 marketing column in Practical Dermatology, a trade magazine for dermatologists, written by the chief executive of a firm that sells marketing to dermatology practices, said a landing-page video can increase conversions by as much as 80 percent, crediting WordStream (Practical Dermatology). Beverly Boy Productions, a video producer selling to dermatologists, says a landing-page video can lift conversion rates by as much as 80% or more, naming no study (Beverly Boy Productions, 2022). We found no dermatology practice test behind the figure.

The larger later evidence points the other way. Unbounce’s own 2021 analysis of about 35,000 customer landing pages in each of three periods (Unbounce) concluded that video appears to have a minimal or negative impact on landing-page performance regardless of the conversion goal (Unbounce). Use instead: do not cite a conversion lift for dermatology video; say Unbounce’s 2021 study of 35,000 pages found video had a minimal or negative effect, and judge a practice’s video by its own appointment requests.

Every popular claim our research pages trace, 816 in all, is on one page: popular video statistics, fact-checked.

How we built this page

We started from the questions people search for about dermatology video statistics and looked for the organization that actually produced each answer. Every figure on this page sits in an evidence ledger with its source, the exact table or paragraph it came from, the measurement period, the population measured, and the date we checked it. This edition holds 630 figures from 75 publishers.

On November 7, 2026, each sourced figure on this page was re-fetched with the fetch cache cleared and matched against the recorded wording: CMS’s Medicare Physician & Other Practitioners files through the data.cms.gov data API and CMS fee schedule and telehealth pages; BLS occupation wage estimates and the Quarterly Census of Employment and Wages (through the BLS data API and data files) and Employment Projections and Occupational Outlook Handbook pages (through Internet Archive copies, because bls.gov refuses automated requests); Census County Business Patterns, Nonemployer Statistics, the 2017 and 2022 Economic Census and the Annual Integrated Economic Survey (through the Census data API); NCI SEER fact sheets and the Cancer Trends Progress Report, CDC pages (Internet Archive copies) and MMWR, the American Cancer Society’s Cancer Facts & Figures 2026 and Florida’s FLHealthCHARTS; NRMP, ACGME, American Board of Dermatology and AAD pages, the AAMC’s physician specialty tables and Florida’s physician workforce report (Internet Archive copies); eCFR, the Federal Register, FDA pages, the 2026 Florida Statutes, the Board of Medicine’s advertising rule and FTC guidance; SEC filings on EDGAR; YouTube and Google Ads help pages; journal abstracts (PubMed abstracts and PMC full texts, re-read through NCBI’s E-utilities because the pages answer scripts with a bot check); and the pages behind each popular claim. Our Medicare counts come from CMS’s own files, our YouTube figures from the YouTube Data API and our filing counts from EDGAR full-text search. We left out JAMA Network and JAAD article pages and congress.gov (robots rules that bar AI agents), parts of the Florida Cancer Data System and State Cancer Profiles sites that their robots rules close, AAD member-only Dermatology World articles, the AAMC’s newer dashboard (it cannot be linked table by table) and CDC’s cancer data tool (it renders only in a browser).

We only cite the producer: government agencies, regulators, company filings and official posts, and the survey owner's own report. We do not cite statistics roundups, Statista-style aggregators, or salary sites without a public method. We did not bypass paywalls or sign-up forms; where a full report was gated, we used only the figures its publisher states publicly.

Figures marked "our calculation" are arithmetic on the cited numbers, and anyone can reproduce them:

This edition contains no Mark Studios customer data.

Limitations

• Dermatologist counts differ by source. BLS counts 11,370 wage-and-salary dermatologist jobs, which leaves out owners of unincorporated practices; CMS lists 12,616 dermatologists who billed Medicare; the AAMC counted 12,756 active dermatologists in 2021; Florida’s survey counts licensed physicians who answer it. We print them side by side rather than pick one.
• Our Medicare figures cover fee-for-service Part B only. They leave out Medicare Advantage, and CMS hides service lines with fewer than 11 patients, so code shares are floors. County totals use each dermatologist’s listed ZIP code. The file has no telehealth flag.
• Physician-office figures are not dermatology figures. BLS and Census count dermatology practices inside offices of physicians (NAICS 621111), shared with every other specialty, and BLS published no 2025 dermatologist estimate for Florida or its metro areas.
• Our YouTube read follows YouTube’s ranking. The 586 videos are what YouTube’s search returned for ‘dermatologist’, ‘skin cancer check’ and ‘acne treatment’ (the top 200 results of each, sorted by views, with no country filter) on November 7, 2026. It is not a census of dermatology video, view counts are lifetime snapshots, and we sorted 277 channels by hand from their public text without checking credentials. We do not name patients.
• Study results come from specific settings. Each content study sampled the top results for one topic on one date and defined “dermatologist” its own way; most education trials were small and run in one or two clinics.
• Association and company figures are their own. The AAD, ASDS and the Skin Cancer Foundation represent or campaign for dermatology, and drug and device makers’ 10-K estimates come from their own market research. Each is labelled.

How to cite this page

For a single figure, cite the original publisher named next to it, and link here if the verification trail is useful to your readers. Each figure has its own anchor, so you can link straight to it, for example https://www.markstudios.com/research/dermatology-video-statistics#DRV-209. To cite the page as a whole:

Mark Studios. "Dermatology Video Statistics." Last verified Nov 7, 2026. https://www.markstudios.com/research/dermatology-video-statistics

@misc{markstudios_dermatology_video_statistics_2026,
  author = {{Mark Studios}},
  title = {{Dermatology Video Statistics}},
  year = {2026},
  month = nov,
  url = {https://www.markstudios.com/research/dermatology-video-statistics},
  note = {Last verified 2026-11-07}
}

Our calculations and the evidence table are free to reuse with attribution and a link to this page. Each underlying figure remains the claim of its original publisher, and some publishers ask for a link when their figures are reused.

Sources

Download the evidence table (CSV)

1. Dermatology Online Journal (St Claire et al.), Dermatology on YouTube - an update and analysis of new trends. (2018-12-15). Accessed 2026-11-07.
2. Journal of Medical Internet Research (Mueller et al.), The Absence of Evidence is Evidence of Non-Sense: Cross-Sectional Study on the Quality of Psoriasis-Related Videos on YouTube and Their Reception by Health Seekers. (2019-01-16). Accessed 2026-11-07.
3. Journal of Medical Internet Research (Mueller et al.), Fiction, Falsehoods, and Few Facts: Cross-Sectional Study on the Content-Related Quality of Atopic Eczema-Related Videos on YouTube. (2020-04-24). Accessed 2026-11-07.
4. Pediatric Dermatology (Zheng et al.), Acne and social media: A cross-sectional study of content quality on TikTok. (2021-01-01). Accessed 2026-11-07.
5. JMIR Dermatology (Subramanyam et al.), Visibility of Board-Certified Dermatologists on TikTok. (2024-01-05). Accessed 2026-11-07.
6. Journal of Drugs in Dermatology (Ward et al.), Acne Information on Instagram: Quality of Content and the Role of Dermatologists on Social Media. (2022-03-01). Accessed 2026-11-07.
7. JMIR Dermatology (Thang et al.), Short-Form Medical Media: A Multi-Platform Analysis of Acne Treatment Information in TikTok Videos, Instagram Reels, and YouTube Shorts. (2023-08-09). Accessed 2026-11-07.
8. Cureus (Irfan et al.), Navigating Digital Dermatology: An Analysis of Acne-Related Content on TikTok. (2023-09-14). Accessed 2026-11-07.
9. Journal of Drugs in Dermatology (Lin et al.), DermTok: Who's Talking Sun? A Cross-Sectional Analysis of Sun Protection Content on TikTok. (2024-07-01). Accessed 2026-11-07.
10. JMIR Dermatology (Roland-McGowan et al.), Perception, Quality, and Accuracy of Sunscreen Content on TikTok: SkinMedia Cross-Sectional Content Analysis. (2025-12-01). Accessed 2026-11-07.
11. JMIR Dermatology (Roland-McGowan et al.), Perception, Quality, and Accuracy of Sunscreen Content on TikTok: SkinMedia Cross-Sectional Content Analysis. (2025-12-01). Accessed 2026-11-07.
12. JMIR Dermatology (Saleh et al.), What's Trending: Cross-Sectional Analysis of the Content and Quality of Popular Melanoma Videos on TikTok. (2026-08-25). Accessed 2026-11-07.
13. JMIR Formative Research (Haddad et al.), Investigating Topical Steroid Withdrawal Videos on TikTok: Cross-Sectional Analysis of the Top 100 Videos. (2024-08-29). Accessed 2026-11-07.
14. Clinical and Experimental Dermatology (Ünlü Açıkel et al.), The reliability and quality of YouTube videos about isotretinoin treatment and suicide. (2024-10-24). Accessed 2026-11-07.
15. International Journal of Dermatology (Rosenberg et al.), Evaluating the Quality of TikTok Videos on Vitiligo: A Cross-Sectional Study. (2025-12-01). Accessed 2026-11-07.
16. JMIR Dermatology (Ranpariya et al.), Patterns of Promotional Content by Dermatology Influencers on TikTok. (2022-03-30). Accessed 2026-11-07.
17. Cutis (Raja et al.), Board-Certified Dermatologists as "Skinfluencers": What Makes Them Famous and Keeps Them Trending? (2026-08-01). Accessed 2026-11-07.
18. Cureus (Irfan et al.), Navigating Digital Dermatology: An Analysis of Acne-Related Content on TikTok. (2023-09-14). Accessed 2026-11-07.
19. Journal of Drugs in Dermatology (Khan et al.), Tips, Trends, and Truths: A Study of Psoriasis Treatment Content on TikTok. (2024-02-01). Accessed 2026-11-07.
20. PLOS Digital Health (Marcon et al.), Sunscreen is overwhelmingly promoted on TikTok, but content with misinformation exhibits proportionally high levels of audience interaction. (2026-06-18). Accessed 2026-11-07.
21. Cancer Control (Herman et al.), Why Don't They Want to Wear Sunscreen? An Observational Study of Anti-Sunscreen Messaging on TikTok. (2026-08-12). Accessed 2026-11-07.
22. Pediatrics (Hales et al.), Pediatric Skin Care Regimens on TikTok. (2025-07-01). Accessed 2026-11-07.
23. Patient Education and Counseling (Armstrong et al.), Effects of video-based, online education on behavioral and knowledge outcomes in sunscreen use: a randomized controlled trial. (2011-05-01). Accessed 2026-11-07.
24. Journal of the American Academy of Dermatology (Armstrong et al.), Online video improves clinical outcomes in adults with atopic dermatitis: a randomized controlled trial. (2011-03-01). Accessed 2026-11-07.
25. Archives of Dermatology (Janda et al.), Impact of a video-based intervention to improve the prevalence of skin self-examination in men 50 years or older: the randomized skin awareness trial. (2011-07-01). Accessed 2026-11-07.
26. Journal of the American Academy of Dermatology (Tuong et al.), Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: a randomized controlled trial. (2014-04-01). Accessed 2026-11-07.
27. Dermatologic Surgery (Delcambre et al.), Using a Multimedia Tool for Informed Consent in Mohs Surgery: A Randomized Trial Measuring Effects on Patient Anxiety, Knowledge, and Satisfaction. (2020-05-01). Accessed 2026-11-07.
28. Dermatologic Surgery (Lin et al.), Brief Educational Video Improves Patient Understanding of Mohs Surgery: A Randomized Controlled Trial. (2021-03-01). Accessed 2026-11-07.
29. JAAD International (Miao et al.), A randomized controlled trial comparing video-assisted informed consent with standard consent for Mohs micrographic surgery. (2020-05-11). Accessed 2026-11-07.
30. Postgraduate Medicine (Savaş Erdoğan et al.), Effect of video-based patient information on patients' anxiety and pain levels before skin biopsy: a randomized controlled study. (2021-11-01). Accessed 2026-11-07.
31. Pediatric Dermatology (Jungwattanavanit et al.), Efficacy of a Video Education Program Regarding Basic Skin Care in Pediatric Atopic Dermatitis: A Randomized Controlled Trial. (2024-11-04). Accessed 2026-11-07.
32. BMJ Open (Bourkas et al.), Diagnostic reliability in teledermatology: a systematic review and a meta-analysis. (2023-08-11). Accessed 2026-11-07.
33. Cochrane Database of Systematic Reviews (Chuchu et al.), Teledermatology for diagnosing skin cancer in adults. (2018-12-04). Accessed 2026-11-07.
34. JAMA Dermatology (Finnane et al.), Teledermatology for the Diagnosis and Management of Skin Cancer: A Systematic Review. (2017-03-01). Accessed 2026-11-07.
35. Telemedicine and e-Health (Dobry et al.), Implementation and Impact of a Store-and-Forward Teledermatology Platform in an Urban Academic Safety-Net Health Care System. (2021-03-01). Accessed 2026-11-07.
36. Clinics in Dermatology (Gronbeck et al.), Increased utilization of teledermatology among Medicare Part B beneficiaries during the COVID-19 pandemic. (2022-09-06). Accessed 2026-11-07.
37. Journal of Drugs in Dermatology (Marson et al.), Characteristic Distinctions Between Pre-/Post-COVID-19 Teledermatology Adoptees: A Cross-Sectional United States-based Analysis and the Implications for Dermatologic Healthcare Equity. (2023-01-01). Accessed 2026-11-07.
38. JAMA Dermatology (Creadore et al.), Insurance Acceptance, Appointment Wait Time, and Dermatologist Access Across Practice Types in the US. (2021-02-01). Accessed 2026-11-07.
39. Clinics in Dermatology (Hakim et al.), Assessing wait times for new dermatology patients: A secret shopper study across United States academic centers. (2026-07-30). Accessed 2026-11-07.
40. JAMA Network Open (Penn et al.), Comparison of Wait Times for New Patients Between the Private Sector and United States Department of Veterans Affairs Medical Centers. (2019-01-04). Accessed 2026-11-07.
41. Journal of the American Academy of Dermatology (Tsang et al.), Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists. (2006-07-01). Accessed 2026-11-07.
42. JAMA Dermatology (Feng et al.), Comparison of Dermatologist Density Between Urban and Rural Counties in the United States. (2018-11-01). Accessed 2026-11-07.
43. Journal of the American Academy of Dermatology (Kasheri et al.), Higher dermatologist density is associated with lower proportions of late-stage melanoma: An ecological study of the State Cancer Profiles. (2026-09-01). Accessed 2026-11-07.
44. Association of American Medical Colleges (AAMC), Active Physicians by Sex and Specialty, 2021 (2022 Physician Specialty Data Report, Table 1.3) (undated). Accessed 2026-11-07.
45. Association of American Medical Colleges (AAMC), Active Physicians by Age and Specialty, 2021 (2022 Physician Specialty Data Report, Table 1.4) (undated). Accessed 2026-11-07.
46. Florida Department of Health, Florida Physician Workforce 2025 Annual Report (2025-11-01). Accessed 2026-11-07.
47. Health Affairs Scholar (Staiger et al.), Who owns your doctor? A decade of trends in physician practice ownership in dermatology and gastroenterology (2026-07-10). Accessed 2026-11-07.
48. JAMA Dermatology (Tan et al.), Trends in Private Equity Acquisition of Dermatology Practices in the United States (2019-09-01). Accessed 2026-11-07.
49. Health Affairs (Braun et al.), Private Equity In Dermatology: Effect On Price, Utilization, And Spending (2021-05). Accessed 2026-11-07.
50. American Academy of Dermatology (association), Sun exposure taking a toll: new AAD survey shows sharp increase in sun damage across the U.S. (2025-04-29). Accessed 2026-11-07.
51. American Society for Dermatologic Surgery (ASDS, association), Dermatologists Top the List as Key Influencers in Patients’ Cosmetic Procedure Decisions (2025-07-28). Accessed 2026-11-07.
52. YouTube (Google), Apply to be a source in YouTube health features - YouTube Help (undated). Accessed 2026-11-07.
53. YouTube (Google), New ways for licensed healthcare professionals to reach people on YouTube - YouTube Blog (2022-10-27). Accessed 2026-11-07.
54. Google Ads (Google), Restricted targeting in Personalized advertising - Advertising Policies Help (undated). Accessed 2026-11-07.
55. Google Ads (Google), Healthcare and medicines - Advertising Policies Help (undated). Accessed 2026-11-07.
56. National Resident Matching Program (NRMP), Results and Data: 2026 Main Residency Match (2026-05-26). Accessed 2026-11-07.
57. National Resident Matching Program (NRMP), Results and Data: 2022 Main Residency Match (revised) (2022-05-31). Accessed 2026-11-07.
58. National Resident Matching Program (NRMP), Charting Outcomes: Characteristics of U.S. MD Seniors Who Matched to Their Preferred Specialty: 2026 Main Residency Match (2026-07-28). Accessed 2026-11-07.
59. Accreditation Council for Graduate Medical Education (ACGME), Data Resource Book, Academic Year 2024-2025 (2026-01-20). Accessed 2026-11-07.
60. American Board of Dermatology (ABD), APPLIED Exam (Passing Candidates of Recent Certification Exams) (undated). Accessed 2026-11-07.
61. American Board of Dermatology (ABD), Micrographic Dermatologic Surgery Subspecialty Exam (Passing Candidates of Recent Certification Exams) (undated). Accessed 2026-11-07.
62. American Board of Dermatology (ABD), What is a Dermatologist? (undated). Accessed 2026-11-07.
63. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-07.
64. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-07.
65. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-07.
66. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2019 data) (2025-03-26). Accessed 2026-11-07.
67. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2019 data) (2025-03-26). Accessed 2026-11-07.
68. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-07.
69. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-07.
70. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-07.
71. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-07.
72. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider (2024 data) (2026-05-21). Accessed 2026-11-07.
73. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
74. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
75. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
76. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
77. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
78. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
79. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2019 data) (2023-05-10). Accessed 2026-11-07.
80. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
81. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2019 data) (2023-05-10). Accessed 2026-11-07.
82. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
83. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
84. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2019 data) (2023-05-10). Accessed 2026-11-07.
85. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
86. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
87. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
88. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2019 data) (2023-05-10). Accessed 2026-11-07.
89. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Geography and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
90. Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners - by Provider and Service (2024 data) (2026-05-21). Accessed 2026-11-07.
91. U.S. Bureau of Labor Statistics, Occupational Outlook Handbook: Physicians and Surgeons (2026-08-27). Accessed 2026-11-07.
92. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-07.
93. U.S. Bureau of Labor Statistics, Employment Projections Table 1.2: Occupational projections, 2025-35, and worker characteristics, 2025 (2026-08-27). Accessed 2026-11-07.
94. U.S. Bureau of Labor Statistics, Occupational Employment and Wages, May 2023: 29-1213 Dermatologists (2024-04-03). Accessed 2026-11-07.
95. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-07.
96. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-07.
97. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-07.
98. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-07.
99. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-07.
100. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-07.
101. U.S. Bureau of Labor Statistics, Occupational Employment and Wage Statistics (OEWS), May 2025 estimates (2026-05-15). Accessed 2026-11-07.
102. U.S. Bureau of Labor Statistics, May 2023 State Occupational Employment and Wage Estimates: Florida (2024-04-03). Accessed 2026-11-07.
103. U.S. Bureau of Labor Statistics, QCEW open data, 2025 annual averages, industry 621111 (2026-09-03). Accessed 2026-11-07.
104. U.S. Bureau of Labor Statistics, QCEW open data, 2019 annual averages, industry 621111 (2020-09-02). Accessed 2026-11-07.
105. U.S. Census Bureau, County Business Patterns 2023 (Census Data API, cbp) (2025-06-26). Accessed 2026-11-07.
106. U.S. Census Bureau, Nonemployer Statistics 2023 (Census Data API, nonemp) (2025-06-26). Accessed 2026-11-07.
107. U.S. Census Bureau, Nonemployer Statistics 2024 (Census Data API, nonemp) (2026-06-25). Accessed 2026-11-07.
108. U.S. Census Bureau, 2022 Economic Census: Selected Statistics by Industry (ecnbasic) (2025-01-23). Accessed 2026-11-07.
109. U.S. Census Bureau, 2017 Economic Census: Selected Statistics by Industry (ecnbasic) (2020-01-30). Accessed 2026-11-07.
110. U.S. Census Bureau, 2022 Economic Census: Products by Industry (ecnnapcsind) (2025-01-23). Accessed 2026-11-07.
111. U.S. Census Bureau, 2022 Economic Census: Revenue by Type of Payer (ecntypepayer) (2025-01-23). Accessed 2026-11-07.
112. U.S. Census Bureau, 2022 Economic Census: Telemedicine Services by Industry (ecntelemeds) (2025-01-23). Accessed 2026-11-07.
113. U.S. Census Bureau, Annual Integrated Economic Survey: Detailed Operating Expenses: 2024 (aiesexp02) (2026-05-28). Accessed 2026-11-07.
114. U.S. Census Bureau, County Business Patterns 2023 (Census Data API, cbp) (2025-06-26). Accessed 2026-11-07.
115. U.S. Census Bureau, County Business Patterns 2023 (Census Data API, cbp) (2025-06-26). Accessed 2026-11-07.
116. U.S. Census Bureau, Vintage 2025 county population estimates (CO-EST2025-ALLDATA) (2026-03-26). Accessed 2026-11-07.
117. U.S. Census Bureau, Vintage 2025 national and state population estimates (NST-EST2025-ALLDATA) (2026-01-27). Accessed 2026-11-07.
118. National Cancer Institute, SEER Program, Cancer Stat Facts: Melanoma of the Skin (2026-04-22). Accessed 2026-11-07.
119. American Cancer Society (nonprofit), Cancer Facts & Figures 2026 (2026-01). Accessed 2026-11-07.
120. American Cancer Society (nonprofit), Key Statistics for Melanoma Skin Cancer (2026-08-12). Accessed 2026-11-07.
121. JAMA Dermatology (Rogers et al.), Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012 (2015-10). Accessed 2026-11-07.
122. American Cancer Society (nonprofit), Key Statistics for Basal Cell Skin Cancer (2026-08-11). Accessed 2026-11-07.
123. Cancer Causes & Control (Kao et al., CDC), Economic burden of skin cancer treatment in the USA: an analysis of the Medical Expenditure Panel Survey Data, 2012-2018 (2022-11-30). Accessed 2026-11-07.
124. American Journal of Preventive Medicine (Guy et al.), Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011 (2014-11-10). Accessed 2026-11-07.
125. Centers for Disease Control and Prevention, Skin Cancer Statistics (2026-06-17). Accessed 2026-11-07.
126. Journal of the American Academy of Dermatology (Lim et al., American Academy of Dermatology), The burden of skin disease in the United States (2017-03-01). Accessed 2026-11-07.
127. JAMA Dermatology (Armstrong et al.), Psoriasis Prevalence in Adults in the United States (2021-08-01). Accessed 2026-11-07.
128. Journal of Investigative Dermatology (Chiesa Fuxench et al.), Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population (2018-10-30). Accessed 2026-11-07.
129. Journal of the American Academy of Dermatology (Collier et al.), The prevalence of acne in adults 20 years and older (2007-10-22). Accessed 2026-11-07.
130. CDC, Morbidity and Mortality Weekly Report (Holman et al.), Prevalence and Context of Sunburn Among U.S. Adults - United States, 2024 (2026-05-21). Accessed 2026-11-07.
131. National Cancer Institute, Cancer Trends Progress Report, Sunburn (2025-04). Accessed 2026-11-07.
132. National Cancer Institute, Cancer Trends Progress Report, Sun-Protective Behavior (2025-04). Accessed 2026-11-07.
133. Journal of Community Health (Holman et al., CDC), Prevalence of Indoor Tanning Among U.S. High School Students from 2009 to 2017 (2019-06-22). Accessed 2026-11-07.
134. National Cancer Institute, Cancer Trends Progress Report, Indoor and Outdoor Tanning (2025-04). Accessed 2026-11-07.
135. Florida Department of Health, FLHealthCHARTS, Melanoma Incidence (FLHealthCHARTS) (2026-11-07). Accessed 2026-11-07.
136. Florida Department of Health, FLHealthCHARTS, Melanoma Incidence (FLHealthCHARTS) (2026-11-07). Accessed 2026-11-07.
137. Florida Department of Health, FLHealthCHARTS, Melanoma Incidence (FLHealthCHARTS) (2026-11-07). Accessed 2026-11-07.
138. Florida Department of Health, FLHealthCHARTS, Deaths From Melanoma (FLHealthCHARTS) (2026-11-07). Accessed 2026-11-07.
139. Florida Department of Health, FLHealthCHARTS, Adults Who Have Ever Been Told They Have Had Skin Cancer (BRFSS) (2026-11-07). Accessed 2026-11-07.
140. STRATA Skin Sciences, Inc., STRATA Skin Sciences, Inc. Form 10-K for fiscal year 2025 (2026-03-26). Accessed 2026-11-07.
141. Verrica Pharmaceuticals Inc., Verrica Pharmaceuticals Inc. Form 10-K for fiscal year 2025 (2026-03-11). Accessed 2026-11-07.
142. Bausch Health Companies Inc., Bausch Health Companies Inc. Form 10-K for fiscal year 2025 (2026-02-19). Accessed 2026-11-07.
143. DermTech, Inc., DermTech, Inc. Form 10-K for fiscal year 2023 (its last annual report) (2024-02-29). Accessed 2026-11-07.
144. Castle Biosciences, Inc., Castle Biosciences, Inc. Form 10-K for fiscal year 2025 (2026-02-26). Accessed 2026-11-07.
145. Sensus Healthcare, Inc., Sensus Healthcare, Inc. Form 10-K for fiscal year 2025 (2026-03-04). Accessed 2026-11-07.
146. Journey Medical Corporation, Journey Medical Corporation Form 10-K for fiscal year 2025 (2026-03-26). Accessed 2026-11-07.
147. Arcutis Biotherapeutics, Inc., Arcutis Biotherapeutics, Inc. Form 10-K for fiscal year 2025 (2026-02-25). Accessed 2026-11-07.
148. Incyte Corporation, Incyte Corporation Form 10-K for fiscal year 2025 (2026-02-10). Accessed 2026-11-07.
149. AbbVie Inc., AbbVie Inc. Form 10-K for fiscal year 2025 (2026-02-20). Accessed 2026-11-07.
150. Biofrontera Inc., Biofrontera Inc. Form 10-K for fiscal year 2025 (2026-03-19). Accessed 2026-11-07.
151. DermTech, Inc., DermTech, Inc. Form 8-K dated June 12, 2024 (Item 1.03 Bankruptcy or Receivership) (2024-06-18). Accessed 2026-11-07.
152. Cutera, Inc., Cutera, Inc. Form 8-K filed March 5, 2025 (Item 1.03 Bankruptcy or Receivership) (2025-03-05). Accessed 2026-11-07.
153. Cutera, Inc., Cutera, Inc. Form 10-K for fiscal year 2023 (its last annual report) (2024-05-10). Accessed 2026-11-07.
154. FS KKR Capital Corp., FS KKR Capital Corp. Form 10-K for fiscal year 2025 (2026-02-25). Accessed 2026-11-07.
155. Nuveen Churchill Direct Lending Corp., Nuveen Churchill Direct Lending Corp. Form 10-K for fiscal year 2025 (2026-02-26). Accessed 2026-11-07.
156. Food and Drug Administration (rule text via eCFR, Office of the Federal Register), 21 CFR 201.327 -- Over-the-counter sunscreen drug products; required labeling based on effectiveness testing (2011-06-17). Accessed 2026-11-07.
157. Food and Drug Administration, FDA Expands Sunscreen Options for the First Time in 20 Years (press announcement) (2026-06-09). Accessed 2026-11-07.
158. Food and Drug Administration, Questions and Answers: FDA's regulatory actions on over-the-counter sunscreen (2026-09-10). Accessed 2026-11-07.
159. Food and Drug Administration (Federal Register), Sunscreen Drug Products for Over-the-Counter Human Use (proposed rule, 84 FR 6204) (2019-02-26). Accessed 2026-11-07.
160. Food and Drug Administration (Federal Register), General and Plastic Surgery Devices: Restricted Sale, Distribution, and Use of Sunlamp Products; Withdrawal of Proposed Rule (91 FR 12524) (2026-03-16). Accessed 2026-11-07.
161. Food and Drug Administration (rule text via eCFR, Office of the Federal Register), 21 CFR 878.4635 -- Sunlamp products and ultraviolet lamps intended for use in sunlamp products (2014-06-02). Accessed 2026-11-07.
162. U.S. Congress (statute text via Legal Information Institute, Cornell Law School), 26 U.S. Code § 5000B - Imposition of tax on indoor tanning services (2010-03-23). Accessed 2026-11-07.
163. The Florida Legislature, The 2026 Florida Statutes, 381.89 Regulation of tanning facilities (2026). Accessed 2026-11-07.
164. Florida Department of State (Florida Administrative Code), Board of Medicine rule, 64B8-11.001 Advertising (2026-03-19). Accessed 2026-11-07.
165. Florida Department of State (Florida Administrative Code), Board of Medicine rule, 64B8-11.001 Advertising (rule text) (2026-03-19). Accessed 2026-11-07.
166. The Florida Legislature, The 2026 Florida Statutes, 458.331 Grounds for disciplinary action; action by the board and department (2026). Accessed 2026-11-07.
167. The Florida Legislature, The 2026 Florida Statutes, 456.072 Grounds for discipline; penalties; enforcement (2026). Accessed 2026-11-07.
168. The Florida Legislature, The 2026 Florida Statutes, 458.3312 Specialties (2026). Accessed 2026-11-07.
169. The Florida Legislature, The 2026 Florida Statutes, 456.062 Advertisement by a health care provider of free or discounted services; required statement (2026). Accessed 2026-11-07.
170. The Florida Legislature, The 2026 Florida Statutes, 499.002 Purpose, administration, and enforcement of and exemption from this part (2026). Accessed 2026-11-07.
171. The Florida Senate (Committee on Rules professional staff), Bill Analysis and Fiscal Impact Statement, SB 172 (Florida Drug and Cosmetic Act) (2020-01-13). Accessed 2026-11-07.
172. The Florida Legislature, The 2026 Florida Statutes, 456.47 Use of telehealth to provide services (2026). Accessed 2026-11-07.
173. Centers for Medicare & Medicaid Services, Telehealth FAQ (updated 10/8/26) (2026-10-08). Accessed 2026-11-07.
174. Federal Trade Commission (rule text via eCFR, Office of the Federal Register), 16 CFR Part 255 -- Guides Concerning Use of Endorsements and Testimonials in Advertising (2023-07-26). Accessed 2026-11-07.
175. Federal Trade Commission (Federal Register), Trade Regulation Rule on the Use of Consumer Reviews and Testimonials (Federal Register, 2024-08-22) (2024-08-22). Accessed 2026-11-07.
176. Federal Trade Commission (staff guidance), Health Products Compliance Guidance (December 2022) (2022-12). Accessed 2026-11-07.
177. U.S. Department of Health and Human Services (rule text via eCFR, Office of the Federal Register), 45 CFR 164.514 -- Other requirements relating to uses and disclosures of protected health information (2026-11-05). Accessed 2026-11-07.
178. Centers for Medicare & Medicaid Services, Calendar Year (CY) 2027 Medicare Physician Fee Schedule Final Rule (fact sheet) (2026-11-04). Accessed 2026-11-07.
179. Arizona Daily Wildcat (University of Arizona student newspaper), crediting AAD and the Arizona Cancer Center, Skin Cancer Facts, July 6, 1994 (1994-07-06). Accessed 2026-11-07.
180. American Academy of Dermatology (professional association), Stop Skin Cancer Before It Stops You (1996 (text refers to 1996; first Wayback capture 1998-04-15)). Accessed 2026-11-07.
181. Journal of the American Academy of Dermatology (Rigel et al.), Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5 (1996-12). Accessed 2026-11-07.
182. The Skin Cancer Foundation (nonprofit association), Skin Cancer Facts - SkinCancer.org (Undated (Wayback capture 2012-01-06)). Accessed 2026-11-07.
183. The Skin Cancer Foundation (nonprofit association), Skin Cancer Facts & Statistics - SkinCancer.org (Undated (Wayback capture 2018-02-08)). Accessed 2026-11-07.
184. Archives of Dermatology (Stern), Prevalence of a history of skin cancer in 2007: results of an incidence-based model (2010-03). Accessed 2026-11-07.
185. The Skin Cancer Foundation (nonprofit association), Skin Cancer Facts & Statistics - The Skin Cancer Foundation (Undated (live page)). Accessed 2026-11-07.
186. American Academy of Dermatology (professional association), Skin cancer | AAD Media (stats) (2026-03-02). Accessed 2026-11-07.
187. Photodermatology, Photoimmunology & Photomedicine (Bech-Thomsen et al.), Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation (1992-12). Accessed 2026-11-07.
188. San Diego Earth Times (monthly), 'provided by the American Dermatological Association' (AAD 55th Annual Meeting material), New sunscreens: protection from damaging rays (1997-08). Accessed 2026-11-07.
189. American Academy of Dermatology (professional association), Cream of the Crop: What to look for in your next bottle of sunscreen (1998 (Skin Savvy 1998; first Wayback capture 1999-01-29)). Accessed 2026-11-07.
190. The Skin Cancer Foundation (nonprofit association), Ask the Expert: Does a higher-SPF sunscreen always protect your skin better? (Undated (first Wayback capture 2012-02-14)). Accessed 2026-11-07.
191. The Skin Cancer Foundation (nonprofit association), The Skin Cancer Foundation Offers Tips on Choosing and Using Sunscreen (2022-06-01). Accessed 2026-11-07.
192. American Academy of Dermatology (professional association), Sunscreen FAQs (2025-02-11). Accessed 2026-11-07.
193. British Journal of Dermatology (Autier et al.), Quantity of sunscreen used by European students (2001-02). Accessed 2026-11-07.
194. Danish Medical Journal (Heerfordt), Sunscreen use at Danish beaches and how to improve coverage (2018-04). Accessed 2026-11-07.
195. British Journal of Dermatology (Faurschou et al.), The relation between sun protection factor and amount of suncreen applied in vivo (2007-04). Accessed 2026-11-07.
196. Journal of the American Academy of Dermatology (Ou-Yang et al.), High-SPF sunscreens (SPF ≥ 70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts (2012-12). Accessed 2026-11-07.
197. American Academy of Dermatology (professional association), citing American Cancer Society 1996 projections, Skin Cancer Fact Sheet (1996-1997 (first Wayback capture 1997-12-10)). Accessed 2026-11-07.
198. British Journal of Dermatology (Pfahlberg et al.), Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation-induced melanoma (2001-03). Accessed 2026-11-07.
199. Cancer Epidemiology, Biomarkers & Prevention (Wu et al.), Long-term ultraviolet flux, other potential risk factors, and skin cancer risk: a cohort study (2014-06). Accessed 2026-11-07.
200. American Academy of Dermatology (professional association), Malignant Melanoma: Issues For The 21st Century (press release, May 2, 1996) (1996-05-02). Accessed 2026-11-07.
201. American Academy of Dermatology (professional association), Skin cancer | American Academy of Dermatology (stats and facts) (Undated (Wayback capture 2019-01-01)). Accessed 2026-11-07.
202. The Skin Cancer Foundation (nonprofit association), Skin Cancer Facts & Statistics - SkinCancer.org (Undated (Wayback capture 2019-07-03)). Accessed 2026-11-07.
203. Journal of the American Academy of Dermatology (Karia et al.), Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012 (2013-06). Accessed 2026-11-07.
204. EyeView Digital (video production and testing vendor; sold the videos it tested), EyeView - The new "Conversion" game (2008-12-04). Accessed 2026-11-07.
205. EyeView Digital (video production and testing vendor; sold the videos it tested), UMOO - a prime beef example of EyeView's success (2009-02-10). Accessed 2026-11-07.
206. EyeView Digital (video production and testing vendor; sold the videos it tested), Another video conversion success story (2009-11-10). Accessed 2026-11-07.
207. EyeView Digital (video production and testing vendor; sold the videos it tested), Making Video Accountable (EyeView white paper) (2010). Accessed 2026-11-07.
208. Unbounce (landing-page software seller), The benefits of using video on landing pages (2010-08). Accessed 2026-11-07.
209. WordStream (PPC advertising software seller), 6 Ways to Use Video to Increase Conversion Rates (2016-03-30). Accessed 2026-11-07.
210. Nucleus Medical Media (healthcare video producer; sells the videos it describes), Current Trends: Healthcare Video Usage on the Web (2018-03-13). Accessed 2026-11-07.
211. Practice Builders (marketing firm selling to medical and dental practices), Video Marketing white paper (2018-03-03). Accessed 2026-11-07.
212. Practical Dermatology (Bryn Mawr Communications trade magazine; column by Naren Arulrajah, Ekwa Marketing, a dermatology marketing seller), Take Your Video Marketing Strategy to the Next Level (2021-09). Accessed 2026-11-07.
213. Beverly Boy Productions (video production company; sells to dermatology practices), Video Production for Dermatologists (2022-07-21). Accessed 2026-11-07.
214. Unbounce (landing-page software seller; analysis of its own customers' pages), Video on landing pages means more conversions, right? Wrong. Here's why (2021-08-26). Accessed 2026-11-07.

Update policy and change log

We re-verify every figure quarterly and when a major source publishes a new edition. The next scheduled review is February 2027. Corrections go to contact@markstudios.com.

• Nov 7, 2026: First published with 630 figures from 75 publishers, each checked against its original source.